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ABSTRACT
The objectives of the first experiment were to ascertain if there were any
differences between two mouse areola and adipose tissue cell lines. These cell
lines differed only in the presence or absence of the hypoxanthine phosphoribosyl
transferase (HPRT) gene. It was found that the cell lines were similar for all
parameters.
The objectives of the second experiment were to determine if the HPRT
gene had an effect on the development of preimplantation mouse embryo. To test
this transgenic mouse lines were created. The embryo sex and genotype ratio, the
embryo diameter, and the embryo developmental patterns, using a Collin-Ryan
Embryo Development (C-RED) score, were determined. The sex and genotype
ratios differed from the expected 1:1. The experiment concluded that HPRT is
effecting embryo development and sex ratios
The objectives of the third experiment were to determine if there is an effect
of sex and HPRT on the cell number of mouse blastocysts. It was found that there
was not an effect of sex, but that HPRT independent of sex was effecting the cell
number of mouse blastocysts.
The objectives of the fourth experiments were to determine if the HPRT
gene in co-culture would have an effect on the development and cell number of
mouse blastocysts. The blastocysts co-cultured with cells containing the HPRT
gene had significantly greater number of blastomeres. This experiment concluded
that HPRT in co-culture can alter the cell number of mouse blastomeres.
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The objective of the fifth experiment was to determine if the same results
that were seen with the HPRT gene in co-culture on mouse embryos could be found
with bovine embryos. There was significantly more blastocyst from co-culture
with the cells containing the HPRT gene. There was not a difference in cell
number of the bovine blastocyst.
The sixth experiment determined the effect of HPRT inhibitors and an
inducer on bovine embryo development and sex ratios. It was found that the
embryos developed with the inducer in the medium did not have altered sex ratios.
The results of these experiments demonstrate that HPRT is effecting
mammalian embryo development.
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INTRODUCTION
Male embryos, even at the preimplantation stage, have been shown to grow
faster than female embryos. This phenomenon has been observed in several
species. While a few research groups have moved beyond the simple reporting of
this fact and conjectured at the causes, none have provided direct experimental
evidence implicating a specific gene.
The following series of experiments are designed to ascertain the effect of
the X-linked gene, hypoxanthine phosphoribosyl transferase (HPRT), on embryo
development in the mouse. The intention is that the identification of a gene
effecting the growth and sex ratio of mouse embryos will be exploited to alter the
preimplantation development of an economically valuable species, such as the cow.
The first experiment is intended to compare and characterize the growth
rates, size and cell integrity of two continuous mouse cell lines. These cell lines
differ only in the presence (HPRT-positive) or absence (HPRT-negative) of the
hypoxanthine phosphoribosyl transferase gene. Data will be collected and analyzed
from 10 passages of the cell lines. The differences in cell number from passage to
passage (both within and between cell lines), the cell diameter and membrane
integrity will be recorded.
Transgenic mouse lines will be created for the second and third
experiments. The embryos from these transgenic lines will be used to compare the
effect of overexpression of HPRT in embryos on the embryonic sex ratio. This will
serve as an indication of the role of HPRT in the sexual dimorphism of mammalian
preimplantation embryos. Information will also be collected on the growth rates,
1

size and cell number of the embryos. This will be in addition to the data
establishing the overexpression of the HPRT gene in the transgenic mouse
embryos.
The fourth experiment will ascertain if any previous effect of HPRT on the
growth and cell number of mouse embryos can be replicated with an extraembryonic source of increased HPRT. To accomplish this mouse embryos will be
co-cultured with cells containing and missing the HPRT gene. The growth of the
embryos will be monitored, and the resulting embryonic cell number will be
determined. The fifth experiment will be identical to the fourth but bovine
embryos will be substituted for the mouse embryos. This will be done to
determine if similar results can be obtained with this economically valuable
species.
The sixth experiment will determine if the pharmacological alteration of the
activity of embryonic HPRT gene will alter the embryo size or sex ratio. This will
be accomplished by exposing bovine embryos, both with and without increased
concentrations of glucose, to several inhibitors or inducers of HPRT. The resulting
sex ratio of the treatment groups and mean diameter of the embryos will be
determined.
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REVIEW OF LITERATURE
Embryo Sexual Dimorphism
Review of Current Knowledge
In recent years it has become accepted fact that mammalian male embryos
develop faster to the blastocyst stage than female embryos (Avery et al., 1989;
Kochhar et al., 2001).
Peippo and Bredbacka (1995), in a complicated experiment with BCf1 mice,
detected a difference in the sex ratio of embryos collected on day 3 of pregnancy
when the embryos were partitioned into three groups based on morphology (less
than 8-cell, 8-cell and compacted morulae). The compacted morula group,
surprisingly, had a significant greater percentage of female embryos. While there
were even numbers of males and females in the 8-cell group; the less than 8-cell
group had fewer female than male embryos, although the disparity was not
significant. To add to the ambiguity of the study, the experimenters proceeded to
follow the development of the embryos for another day in vitro. After this
additional day the number of cells in the embryo was determined and the increase
in the cells reported since the previous day. The report concludes that the male
embryos had a significantly greater increase in the number of cells from the
previous day. So to summarize, this study reported that male embryos had few
cells on day 3 of pregnancy than female embryos, yet the male embryos were
growing faster (as determined by the increase in cell number), so by day-4, male
embryos were significantly more advanced than female embryos. While the
conclusions of this study, that male embryos are growing faster, are interesting, the
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effect of culture media on the growth of the embryos was overlooked. The fact that
culture media may select for faster male embryo growth is not mentioned. This
study also demonstrates an important point. When working with sex differences
and development it is necessary to categorize or select embryos based on a
parameter of development, since a group or cohort of embryos should in the whole
represent a 1:1 ratio. Only by finding the fast or slow developing embryos will the
ratio be skewed. This is particularly important when working with in vivo
embryos, since the culture medium should tend to select for the embryos
developing faster among IVF-derived embryos.
Valdivia et al. (1993) evaluated the sex differences of mouse embryos and
determined that among IVF-derived C57BL/6N mouse embryos a significant
difference in development between male and female embryos at the blastocyst
stage is detectable. This was determined by classifying the embryos based on
blastocoel formation at 72 to 80 hours, with those embryos having cavitated
(formed a blastocoel) at 72 hours classified as fast developing, those cavitating at
80 hours as slow developing and all others as intermediate. As stated above, the
fast developing embryos had a significantly greater number of male embryos and
the opposite is noted with the slow developing embryos, with the intermediates
having an equal number of male and female embryos.
To add to the disparity of development between male and female mouse
embryos, a significant difference in the number of somites of day-9 mouse embryos
at neurulation was reported by Seller and Perkins-Cole (1987). Furthermore,
Tsunoda et al. (1985), using live births as an outcome and sex determination
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method, determined that male embryos developed faster after grouping the embryos
based on the rate of cleavage.
Tarin et al. (1995), in a study with human IVF-derived embryos, a
significant shift in the sex ratio to 90% males were reported in the fast growing
group, with an accompanying 88% females in the slowest growing group. This
extensive report also mentions that the cleavage rate (one parameter of embryo
development) does not alone effect the sex ratio but that maternal age is a
contributing factor. This paper of course brings to light the fact that in vitro
fertilization programs may be inadvertently selecting for sex.
Avery et al. (1991) grouping bovine embryos based on the day of recovery
from cows and the blastocoel size, detected a significant alteration in the sex ratio.
A significant greater number of male embryos were recovered on day 7 of the
estrous cycle, and those males had larger blastocoels based on the embryo grouping
parameters used than the female embryos recovered. Conversely, on day 8 of the
estrous cycle a greater number of female embryos were recovered and, although it
is not significant, the female embryos had larger blastocoels. This study has to be
questioned since the sex determination technique (karyotyping) only produced
results for one-half of the embryos. Still, if it is assumed that the sex of the embryo
does not have an effect on the success of the karyotyping procedure, the results
suggest some interesting conclusions.
Avery et al. (1992) using similar methods with bovine IVF-derived embryos
detected similar results. In this experiment, the embryos were grouped based on
the appearance and relative size of the blastocoel on day 7, day 8 and day 10 after
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in vitro fertilization. As in the previous report with in vivo-produced bovine
embryos, the embryos with larger blastocoels on day 7 were most likely male and
on day 10 were most likely female. The overall sex ratio was exactly 1:1, adding
credence to this study. Unlike the earlier work (Avery et al., 1989), this study was
not hampered by unsexed embryos because the more reliable polymerase chain
reaction method was used to determine the sex.
Carvalho et al. (1996) detected similar results with frozen thawed day-7
bovine IVF-derived embryos. This study graded the embryos based on blastocoel
size on day 7 post-insemination, and as with the previous studies, and detected a
significantly greater number of male embryos in the groups with larger blastocoels.
However, this report did not address a critical issue of the effect of sex and
development on cryopreservation. It is easy to imagine that male embryos having
larger blastocoels, and perhaps a greater number of cells, could respond differently
to the sucrose solutions used in cryopreservation procedures.
The work of Grisart et al. (1995) refuted these previous results on blastocoel
size. This study grouped bovine IVF-derived embryos based on the blastocoel size
and the day of blastocoel appearance. While there was an alteration in favor of
male embryos in all groups none of the values were statistically different, leading
the researchers to conclude that deviation of the sex ratios does not occur in their
culture system.
Using records from Danish Multiple Ovulation and Embryo Transfer
(MOET) program, Callesen et al. (1996) retrospectively graded embryos recovered
from superovulated dairy cows, and using live births resulting from embryo
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transfer as the sex determination method, did not find an alteration of the sex ratio.
The authors were quick to point out the significant differences between in vitro
fertilization and embryo transfer. These include: 1) that the oocytes from in vitro
maturation are considered to constitute a more heterogeneous pool than those
resulting from in vivo maturation; 2) oocytes from IVF programs are selected at
several points and are excluded from further development; 3) the insemination
period during in vitro fertilization is precisely defined; 4) in vitro culture conditions
are very different from the in vivo situation, and more importantly often differ
significantly from laboratory to laboratory (Betteridge and Rieger, 1993).
Thibier and Nibart (1992) compared the sex determination results from both
the polymerase chain reaction and live births, and found a significance difference
was not detectable with either sex determination method. However, unlike many of
the previously mentioned studies, the embryos were not placed into groups based
on development, and as has been pointed out the overall sex ratio did not differ
significantly in these studies; only when developmental stage was considered was a
deviation in the sex ratio detected.
Briefly, it should be mentioned that there is some evidence that many other
factors may effect the sex of embryos. These include the length of the uterus and
ovary (left versus right) from which the oocyte originates (Chen and Dziuk, 1993;
Clark et al., 1994). These studies should not be overemphasized since they are of
an anecdotal nature.
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Possible Causes
Even though these studies suffice to reveal the phenomenon of sexual
dimorphism of preimplantation embryos to date there has not been a serious body
of work investigating the underlying causes of sexual dimorphism. The majority of
statements concerning the mechanism of sexual dimorphism have been primarily
conjecture.
It was originally assumed that the presence of a Y-chromosome was
responsible for the sex differences of mammalian preimplantation embryos (Avery
et al. 1989; Burgoyne et al. 1993; Zwingman et al. 1993). However, closer
investigation of the cellular physiology of mammalian embryos soon revealed that
the activity of two X-chromosomes prior to X-chromosome inactivation was the
most likely cause of sexual dimorphism (Peippo and Bredbacka, 1995).
This has lead to the speculation of which genes may be involved in the
sexual dimorphism of embryos, and since the majority of the research to date
concerning gene activity and embryos has focused on cellular metabolism Peippo
and Bredbacka (1995) focused on the metabolism genes that are linked to the Xchromosome. The most noticeable of these are glucose-6-phosphate
dehydrogenase (G6PD), phosphoglycerate kinase (PGK) and hypoxanthine
phosphoribosyl transferase (HPRT, also known as hypoxanthine-guanine
phosphoribosyl transferase HGPRT). Phosphoglycerate kinase, while it
metabolizes an important reaction of glycolysis is not necessarily the most likely
candidate since glycolytic metabolism does not appear to be very active in
preimplantation embryos (Brackett, 1981). Glucose-6-phosphate dehydrogenase
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does present an enticing picture since it is the rate controlling enzyme of a very
active pathway in preimplantation embryos, the pentose phosphate pathway, and
there has been a report closely linking glucose-6-phosphate dehydrogenase activity
to the sex of the embryo (Tiffin et al. 1991). However, there is not a clear
mechanism proposed by which glucose-6-phosphate dehydrogenase can effect the
development of an embryo, even though the pentose phosphate pathway effects
many cellular functions and more interestingly alters the reactive oxygen species
(ROS) content of cells. This last fact has lead Peippo and Bredbacka (1995) to
speculate that glucose-6-phosphate dehydrogenase and hypoxanthine
phosphoribosyl transferase (another enzyme that can effect the reactive oxygen
species content of cells) are the enzymes responsible for the sexual dimorphism of
embryos by altering the embryo growth in response to altered reactive oxygen
species concentration. While there are reasons to exclude glucose-6-phosphate
dehydrogenase from consideration (Epstein et al., 1978; Kratzer and Gartler, 1978),
the mechanism by which hypoxanthine phosphoribosyl transferase is altering
embryo growth is not related to the reactive oxygen species concentrations as
proposed in Peippo and Bredback (1995), and will be addressed in this dissertation.
Embryo Development and Metabolism
Reactive Oxygen Species and Metabolism
The role of reactive oxygen species should not be disregarded as the cause
of mammalian embryo sexual dimorphism. Reactive oxygen species are oxygen
free radical products of metabolism and the resulting detoxification products (the
most notable is hydrogen peroxide, H2O2) (Voet and Voet, 1990). If these species
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are not acted on quickly by the detoxifying enzymes, namely superoxide dismutase,
cellular damage may occur (Tatemoto et al., 2000). This damage is most often seen
in the plasma membranes and nucleic acids (Aitken et al., 1998). There is some
evidence that reactive oxygen species in certain concentrations can increase
metabolism and have growth stimulating effects (Sohal and Allen, 1990; Reiger,
1992). So it is easy to see how an enzyme that produces reactive oxygen species as
by products can alter developmental rates. This lead Peippo and Bredbacka (1995)
to implicate glucose-6-phosphate dehydrogenase and hypoxanthine phosphoribosyl
transferase in the sexual dimorphism of embryos. Still, a more introspective review
of the metabolism of hypoxanthine phosphoribosyl transferase and glucose-6phosphate dehydrogenase is needed before conclusions concerning their effects on
development can be drawn.
The main parts of embryo metabolism concerning glycolysis, the pentose
phosphate pathway and purine salvage, are outlined in Figure 1. During much of
preimplantation development glycolysis is not active due to the inhibition of
phosphofructose kinase (Pike, 1981). It is not clear when glycolysis becomes
active in preimplantation embryos, but this is most likely species specific and does
not occur until several cell cycles has passed (Boone et al., 1978). This of course
can lead to glucose inhibiting metabolism (possibly by a Crabtree effect; Crabtree,
1925) and even glucose becoming toxic to embryo development (Davis and Day,
1978; Gardner and Lane, 1993; Menezo and Khatchadourian, 1990).
The pentose phosphate pathway, which is controlled by glucose-6phosphate dehydrogenase is, however, quite active even though its activity may not
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Figure 1. Embryo metabolism. Adenine phosphoribosyl transferase (APRT),
hypoxanthine phosphoribosyl transferase (HPRT), inosine monophosphate (IMP),
guanine monophosphate (GMP), adenosine diphosphate (ADP) and adenosine
triphosphate (ATP). (Voet and Voet, 1990).
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be related to the number of X-chromosomes in the embryo (Epstein et al., 1978;
Kratzer and Gartler, 1978). This pathway has two important effects: 1) it produces
NADPH, which can effectively lower the reactive oxygen species concentration
and 2) one of its end products is phosphoribosyl pyrophosphate. Phosphoribosyl
pyrophosphate is a precursor of nucleotide biosynthesis and more importantly of
purine salvage. The activity of hypoxanthine phosphoribosyl transferase will be
addressed in detail further on, but two aspects of the metabolism around
hypoxanthine phosphoribosyl transferase have to be mentioned. First, increased
hypoxanthine metabolism will decrease the amount of the reactive oxygen species
(hydrogen peroxide) produced from the xanthine oxidase pathway (Figure 2).
Second, if de novo purine synthesis is not considered, the available
phosphoribosyl pyrophosphate will be tied up in either adenosine or guanosine
depending on the relative activities of adenine phosphoribosyl transferase and
hypoxanthine phosphoribosyl transferase. There is some evidence that embryos,
like neural cells, rely solely on the salvage enzymes adenine phosphoribosyl
transferase and hypoxanthine phosphoribosyl transferase for purine synthesis
(Wyngaarden, 1959). This is not surprising considering the amount of
hypoxanthine produced from the degradation of the maternal derived mRNA
during genomic activation (Clegg and Piko, 1983). Even though the high energy
phosphates of ATP and GTP are freely transferable thereby, equalizing the free
energy of charge of a cell, the relative activity of hypoxanthine phosphoribosyl
transferase can effect the metabolism of the cell by alter the amount of AMP,
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Figure 2. Hypoxanthine metabolism. Phosphoribosyl pyrophosphate (PRPP;
Jiralespong et al., 1996).
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versus GMP, that is available for phosphorylation to ATP for use by ATP specific
enzymes (such as the Na+/K+ ATPase).
Blastocoel Formation
As noted previous, the majority of experiments reporting a deviation in
embryo development due to sex, have grouped the embryos based on the time of
blastocoel formation and/or blastocoel size. With this in mind, for the purposes of
this dissertation (to ascertain if hypoxanthine phosphoribosyl transferase has an
effect on embryo development and if that enzyme can be manipulated to alter
development) it is necessary to establish a model for blastocoel formation and
maintaince.
Embryo cavitation (the formation of the blastocoel) has fascinated scientist
for almost a century. Melissinos (1907) purposed the first model of cavitation
based on microscopic observations. He observed refractile cytoplasmic droplets
accumulating on the basolateral membrane of the outer blastomere of 16-cell
mouse embryos. The fluid then coalesced to form the blastocoel. This model held
favor for some time. However, the work by Calarco and Brown (1969), Flynn and
Hillman (1978) and Wiley and Eglitis (1980) revealed a problem. Namely, the
droplets did not have the same components as blastocoel fluid.
The second model proposed ~30 years ago is closer to the currently
accepted model (Ducibella and Anderson, 1975). This model states that at the
8-cell stage the outer blastomeres form tight junctions with the other neighboring
blastomeres. Then a movement of ions occurs from the extra-embryonic space
through the outer blastomeres to the nascent blastocoel with an accompanied flow
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of water that causes blastocoel expansion. This model was refuted by Wiley and
Eglitis (1981), when they pointed out that the embryo could not take up extraembryonic fluid with out increasing in volume, and an incidental observations by
McLaren and Smith (1977) which demonstrated that the embryo was not as
impermeable as required for the model to work.
This leads to the metabolic cavitation model currently held to be correct.
This model was originally purposed by Wiley (1984). It states that the droplets
seen by Melissons (1907) are actually lipids that undergo beta-oxidation to produce
high energy compounds. The high energy compounds are then used in the
phosphorylation of AMP to ATP and the resulting ATP is used to drive Na+/K+
ATPases, which are located in the basolateral membrane of the outer blastomeres.
The Na+/K+ ATPases then increase the amount of Na+ in the blastocoel, which
through osmotic pressure drives water into the blastocoel, causing it to expand.
Only the outer blastomeres have tight junctions to maintain the integrity of the fluid
filled blastocoel (Figure 3).
Genomic Activation and X-chromosome Inactivation
Genomic Activation
From the time of fertilization and for at least the first two cell cycles the
embryo is under the control of maternally derived transcripts. At this time the
control of the embryo switches to the embryonic genome. This change in control is
known as genomic activation (Bachvarova and Deleon, 1980). The timing of
genomic activation is species dependent, but believed to occur in all species prior
to compaction at the morula stage (Teleford et al., 1990).
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Figure 3. Metabolic cavitation model. Adenosine diphosphate (ADP), adenosine
triphosphate (ATP), nicotinamide adenine dinucleotide reduced (NADH),
nicotinamide adenine dinucleotide oxidized (NAD+) (Wiley, 1984).
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For the purposes of this report it is interesting to take into consideration the
events of genomic activation and how the embryo deals with this change in
metabolism. During the growth phase of oogenesis RNA synthesis is occurring at
relatively high levels (Figure 4). However, by the time the oocyte leaves diplotene
arrest RNA synthesis has declined to non detectable levels. At this time ~60% of
the RNA is rRNA, 30% is tRNA and 5% is mRNA (Schultz, 1986). Even though
transcription has ceased by this point translation continues using the stored RNA as
machinery for building proteins. This situation remains until the 2-cell stage in
mouse embryos (8- to 16-cell stages in bovine embryo). It is interesting to note
that to our current knowledge genomic activation will usually occur two cell cycles
before the morula begins to compact. During this time, any qualitative or
quantitative changes in protein synthesis occur irrespective to any transcriptional
events (reviewed by Bachvarova, 1985). There is evidence of selective activation
of pre-existing mRNA, and extensive modification to post-translational proteins in
response to external events (Braude et al., 1979; Howlett and Bolton, 1985; Van
Blerkom, 1981). At this stage, the embryo appears to be independent of any
genomic control.
At the 2-cell stage in mouse embryos there is a qualitative change in protein
synthesis that accompanies active transcription from the new embryonic genome
(Bolton et al., 1984). This resumption of transcription is accompanied by a
massive degradation of the maternal-derived transcripts that have been controlling
the development of the embryo up to this point. This degradation of mRNA will
release a vast amount of purines, and since there is little evidence of de novo purine
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Figure 4. Mouse embryo development

synthesis the relative levels of the purine salvage enzymes, adenine phosphoribosyl
transferase and hypoxanthine phosphoribosyl transferase will have a tremendous
impact on the metabolism of the developing embryo (Kochhar et al., 2001).
X-chromosome Inactivation
Of central importance to this research is the developmental process known
as X-chromosome inactivation. During the growth phase of oogenesis, when the
oocyte is arrested in diplotene, both X-chromosomes of the oocyte are
transcriptionally active. Once the oocyte resumes Meiosis-I RNA synthesis
decreases to nondetectable levels. Transcription of the maternal genome ceases
after the first cellular cleavage in the mouse. This is followed by transcription of
the embryonic genome. The embryonic genome contains both the maternal and
paternal derived genetic components. Even though transcription ceases during the
early stage of development, translation continues utilizing the transcripts
accumulated during the growth phase of oogenesis (Wassarman and DePamphilis,
1993) (Figure 4).
Following the completion of Meiosis-I in the oocyte, one of the Xchromosomes is extruded in the first polar body. After fertilization and embryo
genomic activation a female embryo has two transcriptionally active Xchromosomes until X-chromosome inactivation commences at the blastocyst stage
(Monk and Harper, 1979). This can be contrasted to the one transcriptionally
active X-chromosome in male embryos. The inactive X-chromosome in the germ
cells of females is reactivated prior to oogenesis, while the inactive X-chromosome
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of somatic cells remains dormant (Monk and Kathuria, 1977; Kratzer and
Chapman, 1981).
Thus, from the time of genomic activation until blastulation a female
embryo will have twice the amount of hypoxanthine phosphoribosyl transferase
than the male embryos (Monk and Harper, 1979).
Hypoxanthine Phosphoribosyl Transferase
Hypoxanthine phosphoribosyl transferase (HPRT) is a purine salvage
enzyme that catalyzes the reaction of phosphoribosyl pyrophosphate (PRPP) with
hypoxanthine to form the nucleotide inosine monophosphate (IMP). The reaction
is diagramed in Figure 5. Hypoxanthine phosphoribosyl transferase can catalyze
the reaction with guanine in the place of hypoxanthine with the same kinetics
(Figure 6). For this reason hypoxanthine phosphoribosyl transferase is also known
as hypoxanthine-guanine phosphoribosyl transferase (HGPRT) (Konecki et al.,
1982)
Hypoxanthine is a nontoxic intermediate in the catabolism of purine
nucleotides (Figure 7). If it is not acted on by hypoxanthine phosphoribosyl
transferase it will be further degraded to uric acid by xanthine oxidase, a pathway
that produces two moles of the reactive oxygen species hydrogen peroxide for each
mole of hypoxanthine (Figure 2). If hypoxanthine is acted on by hypoxanthine
phosphoribosyl transferase, inosine monophosphate will be the product, which can
serve as the precursor of adenosine monophosphate (AMP) and guanine
monophosphate (GMP). As stated earlier, there is an accompanying enzyme that
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Figure 5. The hypoxanthine phosphoribosyl transferase reaction.
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salvages adenine, adenine phosphoribosyl transferase, and converts it directly to
AMP.
The mouse hypoxanthine phosphoribosyl transferase cDNA was originally
isolated by Konecki et al. (1982). The mRNA is 1,292 base pairs in length. It has
an 87 base pair 5’ noncoding sequence preceding a 657 base pair open reading
frame. This is followed by 548 base pairs of a 3’ noncoding sequence that contains
three polyadenylation signals, two of which are over lapping.
The open reading frame of the mouse hypoxanthine phosphoribosyl
transferase mRNA codes for a 218 amino acid residue protein. This protein is
highly conserved in all mammals studied thus far, with greater than 95% homology
(Jiralerspong et al., 1996).
The mouse hypoxanthine phosphoribosyl transferase gene is a 33 kilobase
gene containing 9 exons and is located on the long arm (Xq26-q27) of the mouse
X-chromosome (Shows and Brown, 1975).
Hypoxanthine phosphoribosyl transferase is considered a housekeeping
gene since it is expressed at detectable levels in every tissue. There is evidence that
hypoxanthine phosphoribosyl transferase is responsible for the majority of the
purines in the brain (Jiralerspong et al., 1996). Since hypoxanthine phosphoribosyl
transferase is highly conserved and the sequence has been known for a long time, it
is used often in mutation studies where any alteration of its sequence can be
detected easily. The hypoxanthine phosphoribosyl transferase gene has also proved
useful in cell culture studies since its product is selectable. Cells when cultured in
medium containing HAT supplement (hypoxanthine, aminopterin, thymine) will
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cease de novo purine and thymine production due to the aminopterin and will rely
on the purine salvage enzyme hypoxanthine phosphoribosyl transferase for purines.
If hypoxanthine phosphoribosyl transferase is not present in the cell, the cell will be
missing purines and die (Freshney, 1987).
Gout and Lesch-Nyhan Syndrome
Hypoxanthine phosphoribosyl transferase is associated with two diseases;
gout and Lesch-Nyhan syndrome (Voet and Voet, 1990). Gout is a disease
characterized by excess production of uric acid in body fluids. The most common
manifestation is excruciating joint inflammation (most often in the big toes). This
is due to the deposition of uric acid crystals in the joints. More seriously, uric acid
crystals may be deposited in the kidneys causing renal damage and potentially life
threatening renal failure. The uric acid is accumulated through over activity of the
xanthine oxidase pathway. One cause of the over production of uric acid is a
deficiency in hypoxanthine phosphoribosyl transferase, leading to less purine being
salvage and more being degraded to uric acid. This is one reason gout most often
affects males, it is, in the case of hypoxanthine phosphoribosyl transferase
deficiency, a sex-linked genetic disease for which males are not fortunate enough to
have an extra allele of the gene. Gout is commonly treated by allopurinol
administration. The allopurinol is metabolized by xanthine oxidase to alloxanthine,
which irreversible binds the xanthine oxidase inactivating it (Kelley, 1967; Voet
and Voet, 1990).
Lesch-Nyhan syndrome is a distructive disease that is sex-linked and
genetic (Lesch and Nyhan, 1964). It is characterized by mental retardation and
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grotesque self-mutilation. Even though the exact method is still unknown it is
caused by a complete lack of functional hypoxanthine phosphoribosyl transferase.
The disease, does not present itself until a couple years of life when some self
mutilation behavior, such as lip biting and eye gauging, is followed by a noticeable
mental retardation. The prognosis is not favorable for the afflicted individuals, and
they tend to succumb to wounds or infections arising from the self mutilation
behavior. Very few survive to the teenage years. Unfortunately, the individuals
with the disease are not severely mentally retarded, invariablely present themselves
with a pleasant happy character, and gravest of all appear to be well aware of the
detrimental results of the acts of self mutilation.
There has been a reported case of a female with Lesch-Nyhan syndrome
(Hara et al., 1982). The carrier females do not present any signs of the syndrome,
even though some of their tissues lack hypoxanthine phosphoribosyl transferase
activity due to random inactivation of the X-chromosome (Hara et al., 1982).
Finally, knockout mouse models of the disease do not exhibit the self mutilation
behavior, but do exhibit some signs of retardation (Dunnett et al., 1989). These
animals have not proven to be the ideal model system for the study of LeschNyhans syndrome, but they have been shown to be useful in the study of
hypoxanthine maintained arrest of mouse oocyte maturation (Downs, 1997a).
Hypoxanthine Phosphoribosyl Transferase and Development
To date the majority of work with hypoxanthine phosphoribosyl transferase
and development has centered on three areas: 1) oocyte maturation, 2) mouse 2-cell
in vitro developmental block and 3) X-chromosome inactivation.
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The latter area has mostly been concerned with the use of hypoxanthine
phosphoribosyl transferase as a maker for X-chromosome inactivation (Monk and
Harper, 1978). Hypoxanthine phosphoribosyl transferase has never been
implicated in any way with the mechanism of X-chromosome inactivation.
However, its use as an indicator of X-chromosome inactivation has led to the
revelation of some interesting relationships between, hypoxanthine phosphoribosyl
transferase and embryo development that will be discussed here.
It is apparent that hypoxanthine phosphoribosyl transferase is present and
active in the embryo prior to genomic activation (Kratzer, 1983). This of course
leads to the correct assumption that the hypoxanthine phosphoribosyl transferase at
this stage is a result of transcription of the maternal genome of the oocyte during
oocyte maturation (Harper and Monk, 1978). Similarly, there is evidence that
hypoxanthine phosphoribosyl transferase is present and active in the embryos after
genomic activation (Monk and Kathuria, 1977). However, not only is this activity
from the embryonic genome but it is clear that the level of activity is dictated by
the number of X-chromosomes contained in the embryonic genome (Moore and
Whittingham, 1992).
Hypoxanthine phosphoribosyl transferase activity shows a slight increase
from the time of oocyte maturation to the activation of the embryonic genome.
Following genomic activation, however, hypoxanthine phosphoribosyl transferase
begins to increase exponentially in the female embryos with male embryos on
average having one-half the activity (Kratzer and Gartler, 1978; Kratzer, 1983). In
a population of mouse embryos the pattern of hypoxanthine phosphoribosyl
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transferase expression will be bimodal until the late blastocyst stage, when the
mode with the greater amount of activity begins to diminish until there is only one
mode, indicating that X-chromosome inactivation has occurred. Monk and Harper
(1978) concluded that X-chromosome inactivation occurs during blastulation.
Even though the majority of this work has been accomplished with mouse embryos,
similar results have been found with other species, including bovine embryos
(Bernardi et al., 1996; Gutierrez-Aden et al., 2000).
Hypoxanthine phosphoribosyl transferase has also been extensively studied
in its relation to the developmental arrest of 2-cell mouse embryos (2-cell in vitro
developmental block). Preimplantation mouse embryos of some strains exhibit a
developmental arrest that occurs in G2 of the second or third cell cycle (Dienhart et
al., 1997). This developmental arrest is aggravated in vitro by the presence of
hypoxanthine, and is dependent on the presence of glucose in the medium (Downs
and Dow, 1991). The in vitro developmental block can also be reversed by
incubating the embryos with compounds that elevate cAMP levels. This implies an
antagonistic relationship between the products of the purine salvage pathways,
AMP (a precursor of cAMP) from adenine and GMP from hypoxanthine (Voet and
Voet, 1990). Even though hypoxanthine phosphoribosyl transferase has been
shown to play a role in the developmental arrest caused by hypoxanthine, the
mechanism by which the products of hypoxanthine phosphoribosyl transferase are
causing this in vitro developmental block have not, to date, been elucidated
(Deinhart et al., 1997).
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Finally, the role of hypoxanthine phosphoribosyl transferase in oocyte
maturation has received much attention. Hypoxanthine is a known component of
follicular fluid and when added to oocyte maturation medium can cause them cease
maturation (Downs, 1997b). This inhibitory effect has been seen in many species.
It is believed that the requirement of the substrate, phosphoribosyl pyrophosphate,
by both adenosine phosphoribosyl transferase and hypoxanthine phosphoribosyl
transferase is the underlying mechanism causing the arrest of oocyte maturation by
hypoxanthine (Downs, 1997a).
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THE EFFECT OF HYPOXANTHINE PHOSPHORIBOSYL
TRANSFERASE ON MOUSE ADIPOSE AND AREOLAR CELL GROWTH
Introduction
Hypoxanthine phosphoribosyl transferase (HPRT) is a purine salvage
enzyme (Voet and Voet, 1990). It is responsible for converting the purine
degradation product, hypoxanthine, to inosine monophosphate, a precursor of
adenosine triphosphate (ATP) and guanine triphosphate (GTP) (Konecki et al.,
1982). The reaction catalysed by hypoxanthine phosphoribosyl transferase is the
substitution of the 1’pyrophosphate (H2P2O7) group of phosphoribosyl
pyrophosphate with hypoxanthine.
In the absence of HPRT hypoxanthine is degraded to uric acid by the
enzyme xanthine oxidase. This degradation of hypoxanthine produces two moles
of the reactive oxygen species, hydrogen peroxide (H2O2) for each mole of
hypoxanthine degraded (Jiralerspong et al., 1996).
Reactive oxygen species, such as hydrogen peroxide, can cause severe
cellular damage to organelles and especially phospholipid membranes, if they are
not acted on by superoxide dismutase and catalase for conversion to benign water
(Rieger, 1992). However, reactive oxygen species are also required for normal
cellular function and growth, and in some cases have been shown to increase
cellular metabolism (Shoal and Allen 1990). Therefore, increased levels of
hypoxanthine phosphoribosyl transferase could serve to protect the cell from
damage, by preventing the production of hydrogen peroxide, while decreasing
metabolism and growth.
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To determine the effect of hypoxanthine phosphoribosyl transferase on cell
growth and health in culture this study is to compare the growth rates, cellular size
and membrane integrity of two cell lines, one with the hypoxanthine
phosphoribosyl transferase gene and one without the hypoxanthine phosphoribosyl
transferase gene.
The HPRT-positive cell line was derived from mouse subcutaneous areolar
and adipose tissue by Sanford et al. (1948), and was one of the first cell lines
established for continuous cell culture. These cells grow in the presence of HAT
(hypoxanthine, aminopterin and thymine) supplementation and require fetal bovine
serum for normal growth.
The HPRT-negative cell line was derived from the HPRT-positive cell line
by Littlefield (1963), and is used for hybridoma production. The HPRT-negative
cells are sensitive to HAT supplementation and like the HPRT-positive cells
require fetal bovine serum for normal growth.
Materials and Methods
Cell Lines
Two cell lines, one with hypoxanthine phosphoribosyl transferase activity
(CCL-1.0) and one without hypoxanthine phosphoribosyl transferase activity
(CCL1.4), were purchased from American Type Culture Collection (ATCC,
Rockville, MD), and will be referred to here as HPRT-positive and HPRT-negative,
respectively (Figure 8).
The HPRT-positive cell line was derived from the subcutaneous areolar and
adipose tissue of a 100-day-old male C3H/An mouse in 1948 and is one of the first
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Figure 8. The HPRT-positive (upper) and HPRT-negative cells (lower) (20X
objectives).
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cell lines established in a continuous culture system (Sanford et al., 1948). The
HPRT-negative cell line was isolated from the HPRT-positive cell line by
Littlefield (1963). They are deficient in the HPRT gene making them sensitive to
HAT (hypoxanthine, aminopterin and thymidine) selection. The sensitivity and
insensitivity of the HPRT-negative and HPRT-positive cell lines was confirmed
prior to this experiment by culture for 3 days in the presence of HAT
supplementation (data not shown).
The cell lines prior to the start of this experiment were maintained in 75 cm2
(Falcon) tissue culture flasks with 7.5 ml of Debeccules Modified Eagle’s Medium
(DMEM, Gibco, Bethesda, MD) supplemented with 5% fetal bovine serum at 37oC
in 5% CO2 air. The cultures were passaged every 3 days by removing the 7.5 ml of
DMEM and adding 5 ml of 0.01% Trypsin-EDTA (Gibco, Bethesda, MD). The
cells were allowed to detach for 5 minutes at room temperature. A 4.5-ml volume
of the resulting cell suspension was disposed of and to the remaining 0.5 ml of cell
suspension 7 ml of DMEM was added and the flask returned to the 37oC and 5%
CO2 in air.
Experimental Design
A total of 500,000 cells of either the HPRT-positive (Treatment A) or
HPRT-negative (Treatment B) cell line was used to seed 25 cm2 tissue culture
flasks. This seeding was replicated 5 times. The cells were incubated in 3 ml of
DMEM with 5% fetal bovine serum at 37oC and 5% CO2 in air. Every 48 hours for
480 hours the cells were incubated (the cultures were between 90 and 95%
confluent at each passage) and data were collected.
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The 3 ml of DMEM was removed and 3 ml of 0.01% Trypsin-EDTA
(Gibco, Bethesda, MD) was added and allowed to stand at room temperature
(25oC) until all cells had detached, which was confirmed by observation with a
Nikon inverted Diaphot microscope at 100X magnification. All but 0.5 ml of the
0.01% Trypisin-EDTA cell suspension (between 178,000 and 611,000 cells) was
removed to which 2.5 ml of DMEM was added and the cultures returned to the
incubator for the next 48 hours.
The remaining 2.5 ml of the 0.01% Trypsin-EDTA cell suspension was
used to obtain the mean cell diameter, membrane integrity and cell counts. These
counts were made using a Improved Neubauer hemacytometer at 100X
magnification on a Nikon inverted Diaphot microscope. The procedure used for
counting cells in vitro has been previously reported by Freshney (1987). The
equation used to determine the number of cells is as follows:
Cell Count = (no. of cells counted) (1 x 104) ÷ (4) (volume of cell suspension)
The mean number of cells at each passage/culture flask, as well as the increase in
cell number/flask was then determined every 48 hours.
The mean cell diameter was determined by photographing 10 µl of the cell
suspension place on a glass slide with a Nikon inverted Diaphot microscope with
20X objectives and a Cannon SLR 35 mm AE1 camera using 400 ASA
KodaChrome color slide film. After development of the film the images were
scanned using a Microtek 35t color slide scanner at 200 dpi. The mean diameter of
the cells was determined using measure tool of Adobe Photoshop 5.0 that had been
calibrated with a stage micrometer. Measurements for the mean diameter for each
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cell line at each passage were determined by averaging the diameters of 2 axes
from three randomly chosen cells. This was replicated 5 times with each cell line.
The membrane integrity was determined by adding 2 µg of propidium
iodide (Sigma, St. Louis, MO) and 2 µg of Hoechst 33324 (Sigma, St. Louis, MO)
to 100 µl of the cell suspension. Propidium iodide will only fluoresce red when
bound to the nuclear DNA of cells with compromised membranes that do not
exclude the dye. Hoechst 33342 will bind to the nuclear DNA of cells with and
without intact membranes and fluoresce blue. Cells with both propridium iodide
and Hoechst 33324 fluorescence have a color slightly on the orange side of red.
The cells were photographed using the procedure stated above but with ultraviolet
illumination. The percent of cells with intact membranes were then determined by
counting the 10 cells nearest the upper left hand corner of the scanned developed
film. As stated in the results section the photographing of the fluorescent cells was
ceased at the third passage, however, visual observation of the cells using a Nikon
Diaphot microscope with 20X objectives was continued.
Statistical Analysis
An analysis of variance was used to detect significant differences in the
mean number of cells, increase in cell number and mean cell diameter at each
passage (Freshney, 1987). A simple regression model was used to determine the
differences in growth between cell lines over the course of the experiment
(Freshney, 1987).
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Results
For the first three subpassages there was not a difference in the membrane
integrity because none of the cells in the photographs were flourescening orange as
would be expected with propidium iodide and Hoechst 33324 staining. Further
investigation at the fourth subpassage revealed that there were less than 10
cells/100,000 cells with compromised membranes. This led to cessation of the
photographing after the third subpassage, however, the cells were observed visually
for the remainder of the experiment.
The mean cell number/cell line at each subpassage is presented in Figure 9.
There was a significant difference in the number of cells at the first, second, ninth
and tenth subpassages (P<0.05). There was not a significant difference in the
mean number of cells at each 48-hour subpassage within cell lines. The growth
rates of the two cell lines (Treatment A and Treatment B) were not significantly
different. The increase in cell number between the two cell lines (Treatment A and
Treatment B) at each subpassage is significantly different (P<0.05) at the first two
and last two subpassages (Figure 10).
There was not a significant difference in the mean cell diameter measured at
any subpassage (Figure 11). The mean cell diameter at the first subpassage was
30 µ (Treatment A) and 36.3 µ (Treatment B). The mean cell diameter at the last
subpassage was 24.5 µ (Treatment A) and 28.4 µ (Treatment B).
Discussion
Mouse HPRT cDNA was isolated by Konecki et al. (1982). The mRNA has
a 87 base pair 5’ noncoding sequence situated upstream of the 657 base pair open
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Figure 10. The mean (±SE) increase in cells at each subpassage for the HPRTpositive and HPRT-negative cell lines. a,bBars with different superscripts are
significantly different (P<0.05).
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480

reading frame. There are 548 base pairs of a 3’ noncoding sequence that contains
three polyadenlylation signals. Two of the polyadenylation signals are
overlapping. The mRNA is 1,292 base pairs in length (Konecki et al., 1982).
The HPRT protein, coded from the open reading frame, has 218 amino acid
residues. In all mammals studied thus far the protein is highly conserved, with
greater than 95% homology (Jiralerspong et al., 1996).
The gene for HPRT contains 9 exons and is located on the long arm (Xq26q27) of the mouse X-chromosome. The HPRT gene is 33 kilobases in length
(Shows and Brown, 1975).
HPRT is responsible for the majority of purines produced in the brain
(Jiralespong et al., 1996). Mutations of the HPRT gene is responsible for two
diseases; Lesch-Nyhan syndrome and gout (Lesch and Nyhan, 1964; Kelly, 1967).
HPRT can alter the reactive oxygen specie content of cells by effecting the
activity of the pentose phosphate pathway and shifting the metabolism of purines
away from the reactive oxygen specie producing purine degradation pathway
(Jiralerspong et al., 1996). However, HPRT can have a more direct action on the
metabolism of cells by altering the relative abundance of ATP and GTP (Konecki
et al., 1982).
Based on the data from the membrane integrity potion of this experiment,
the absence of HPRT is not causing any detectable damage to the cell lines used in
this study. This is surprising since the work of Sohal and Allen (1990) indicates
that the absence of HPRT should result in significant membrane damage. HPRT is
known to effect the reactive oxygen species content of cells (Rieger, 1992). It is
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possible that the dye exclusion technique used here is not sensitive enough to detect
a difference in reactive oxygen species damage.
Several groups have reported differences in the growth rates of mammalian
embryos with male embryos developing faster (Avery et al., 1991; Callesen et al.,
1995; Tarin et al., 1995). The activity of HPRT in mouse embryos prior to Xchromosome inactivation is associated with the sex of the embryo (Monk and
Harper, 1978). Female embryos have twice the amount of HPRT activity than male
mouse embryos (Monk and Kathuria, 1977). This association of embryo sex and
HPRT activity has also been reported with bovine embryos (Gutierrez-Adan et al.,
2000).
An alteration in the rate of growth between male and female pig embryos
was reported by Cassar et al. (1994). This alteration in the growth of pig embryos
was seen when comparing the embryos before and after hatching. Xu et al. (1992)
observed faster development of the blastocoel in male bovine embryos compared
with female bovine embryos. Similar results were seen by Avery et al. (1989) with
bovine embryos. This finding was supported by the same group with IVF-derived
embryos (Avery et al., 1991). Avery et al. (1992) confirmed the results of these
previous experiments. The male IVF-derived bovine embryos in the latter study
formed blastocoels faster than the female embryos.
The faster rate of male embryo development has been attributed to the
activity of the Y-chromosome by several studies (Avery et al., 1989; Avery et al.,
1991; Avery et al., 1992). However, Xu et al. (1992) indicated that the difference
in the rate of growth of male embryos compared with female embryos was due to
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the activity of two X-chromosomes in the female embryos. This stance has also
been taken by Callesen et al. (1995).
Studying bovine embryos, Bredbacka and Bredbacka (1996) indicated that
HPRT is the gene responsible for the faster growth of male embryos. In addition,
Bredbacka and Bredbacka (1996) claimed that the faster rate of growth of the male
embryos was a consequence of the effect of HPRT on the reactive oxygen species
content of the cell. This view was supported by the same group with mouse
embryos (Peippo and Bredbacka, 1995). Similarly, Gutierrez-Adan et al. (2000)
have advocated the effect of HPRT on the reactive oxygen species content of
embryo cells as the cause of faster male bovine embryo growth.
In the current study an effect of HPRT activity on the mean cell diameter
was not detected. This could be the result of the limited numbers of cells measured
or this could reflect the limitation of the techniques used to determine the cell
diameter. This was an unexpected finding based on the results of Bredbacka and
Bredbacka (1996).
There was not a consistent difference in the mean number of HPRT-positive
cells compared with HPRT-negative cells during the course of this experiment.
This finding, taken with the other finding of this experiment (that HPRT does not
effect cell diameter), indicates that HPRT does not have an effect on hyperplasia or
hypertrophy of the HPRT-positive or HPRT-negative cells used in this experiment.
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OVER EXPRESSION OF THE HPRT GENE IN PREIMPLANTATION
MOUSE EMBRYOS ALTERS THE EXPECTED SEX RATIO AND
HINDERS BLASTOCEOL FORMATION
Introduction
In domestic animal embryo transfer practices, it is common to lack recipient
females for embryo transfer. Similarly, in human IVF programs the state of
recipient uterus can not be dictated. Therefore, the ability to dictate the rate of
preimplantation embryo development has implication for human IVF programs.
Other fields, such as experimental mouse embryo production and bovine embryo
transfer, will also benefit from the greater control of embryo development.
There is evidence that sexual dimorphism exists in preimplantation
embryos. This has been reported in mice (Valdivia et al., 1993; Tusonda et al.,
1985), cattle (Avery et al., 1989; Avery et al., 1991; Avery et al., 1992), pigs
(Cassar et al., 1994) and humans (Tarin et al., 1995). In these studies, male
embryos tended to have faster blastocoel formation. While some groups (Tusonda
et al., 1985; Avery et al., 1989) have proposed a Y-chromosome factor as the agent
of accelerated male development, others indicate that the increased expression of
X-linked genes prior to X-chromosome inactivation retards the female embryos
(Bredbacka and Bredbacka, 1996; Bredbacka, 2001). Even though sexual
dimorphism of preimplantation embryos is likely due to the action of multiple
genes, the elucidation of only one of the genes leading to the altered developmental
rates may allow extraneous control of development by control of the endogenous
gene.
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The present study was undertaken to determine if the X-linked gene
hypoxanthine phosphoribosyl transferase (HPRT) has an effect on the rate of
embryo development. Hypoxanthine phosphoribosyl transferase converts the
purine degradation product hypoxanthine to inosine thereby, bypassing the
xanthine oxidase pathway that increases reactive oxygen species (H2O2) levels,
effectively lowering the oxygen radical content of the cells (Sohal and Allen,
1990). The fact that oxygen radicals may stimulate growth as reported by Reiger
(1992) has lead Peippo and Bredbacka (1995) to speculate that the cellular effect of
HPRT may be responsible for the sexual dimorphism of preimplantation embryos.
The first model of blastocoel formation was proposed by Melissinos (1907).
This model was founded on the coalescence of refractile droplets in mouse
embryos. Ducibella and Anderson (1975) presented a model of blastocoel
formation based on the presence of tight junctions formed by the outer blastomeres
of compacted mouse morulae and the movement of ions from the extra-embryonic
space to the blastocoel. The currently accepted model states that lipids in the outer
blastomeres undergo beta-oxidation to form ATP (Wiley, 1984). This ATP is used
to drive Na+/K+ ATPases in the basolateral membrane of outer blastomeres. This
increases the amount of Na+ in the blastocoel causing a flow of water into the
blastocoel with the resulting increase in blastocoel size.
While research has been conducted on hypoxanthine phosphoribosyl
transferase, its actions on oocytes maturation and the mouse 2-cell block, the effect
of this gene on compaction and blastulation has not been extensively studied
(Dienhart et al., 1997; Downs and Dow, 1991; Downs et al., 1998). This study uses
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transgenic mouse embryos over expressing HPRT to determine if this gene has an
effect on the sex ratio and development of mouse embryos.
Materials and Methods
HPRT Expression Construct
The full length mouse HPRT cDNA (Konecki et al., 1992, ATCC #37424)
was positioned downstream of the phosphoglycerate kinase (PGK) promoter
(Figure 12). Briefly, the agouti fragment was excised from the PGK-agouti
plasmid (Klebig et al., 1995) by PstI digestion and replaced with a PstI fragment
containing the full length mouse HPRT cDNA. The PGK promoter was selected
due to its known endogenous ubiquitous expression during all stages of
preimplantation development (Monk, 1987). Correct orientation of the HPRT
cDNA was determined by HindIII digestion and the plasmid designated
pLSUMC2.0(+).
Transgenic Mice
The EcoRI-ApaI fragment of pLSUMC2.0(+), containing the PGK
promoter, HPRT cDNA and PGK polyadenylation signal (HPRT transgene), was
injected into the pronucleus of FVB/N sperm-exposed ovum and transgenic mice
derived as described by Hogan et al. (1994) (Figure 13).
Briefly, the HPRT transgene at a concentration of 3 ng/ml of Tris-EDTA
(pH 8.0) was injected into one of the two pronuclei of the FVB/N sperm-exposed
ovum (The sperm-exposed ovum were collected from mice, from Jackson
Laboratories, that were between 4 and 8 weeks-of-age and were maintained on
Purina rodent chow (Sigma, St. Louis, MO) at 4 or less mice/cage.) by holding the
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Figure 12. The pLSUMC2.0(+) construct.
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Figure 13. The HPRT transgene construct.
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ovum with a micromanipulator equipped with a holding pipette. The HPRT
transgene was then injected into the pronucleus by passing the injection pipette
(< 1.0 µ diameter) through the zona pelucida, oolemma and pronuclear membrane.
Positive pressure was applied until the pronucleus had expanded by at least twice
the original size. The injection pipette was then removed from the embryo and
following overnight culture under the conditions described herein. The surviving
embryos were transferred to the oviducts of CD-1 mice mated to vasectomized
male FVB/N mice. Live pups were weaned 21 days following birth and genotyped
using the Maxi-Prep Kit (Quiagen, Rheimstein, Germany).
RNA (Northern) Blot Analysis
Northern-blot hybridization analyses was performed as described by
Ausudel et al. (1989) on total RNA from the gonads, liver, heart and brain of adult
transgenic (Tg/-) mice and nontransgenic littermates of both sexes for comparison.
The liver, heart and brain were selected as representative tissues of each embryonic
germ layer (endoderm, mesoderm and ectoderm, respectively). The full length
mouse HPRT cDNA referenced above was used as a probe.
Embryo Collection and Culture Conditions
Female FVB/N mice were primed with 5 IU of equine chorionic
gonadotropin (Sigma, St. Louis, MO), followed by 5 IU of human chorionic
gonadotropin (Sigma, St. Louis, MO) 46 hours later. Following administration of
human chorionic gonadotropin the females were placed with male mice
hemizygous for the HPRT transgene. The male mice were derived from one of two
lines TgN(HPRT)ARlm (referred to as HPRT-A) and TgN(HPRT)BRlm (referred
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to as HPRT-B) resulting from a pronuclear injection procedure. All animals were
maintained on a 12-hour light-dark cycle with coitus calculated to be at 12:00 pm.
The following morning sperm-exposed ovum were isolated from females exhibiting
vaginal plugs. The embryo collection was performed by sacrificing the animals by
cervical dislocation and removing the oviducts. The oviducts were placed into
M16 medium (Hogan et al., 1994; Sigma, St. Louis, MO) and the cumulus cell
masses removed with a 26-gauge needle. Embryos obtained from the same lines
were pooled for each replicate.
Following collection the embryos were incubated 24 hours in 100 µl of M16
medium (Sigma, St. Louis, MO). After 24 hours, the embryos were transferred to
100 µl of M16 medium with 4 mg/ml of bovine serum albumin (BSA, Fraction-V,
Sigma, St. Louis, MO) for a additional 24 hours in culture. At that time point (48
hours after embryo collection) any embryo exhibiting signs of compaction were
placed into individual droplets of M16 medium with 4 mg/ml of BSA. The
medium was changed at 24-hour intervals for the remainder of culture. Embryos
were cultured at 5% CO2 air and 37oC.
Embryo Evaluation
Beginning 72 hours post-coitum (pc) embryos were assigned a Collins-RED
score (C-RED), which is based on morphology of development (Tables 1 and 2).
The C-RED score was adapted for use with mouse embryos from the RED score
reported by Ryan et al. (1992) for use with in vitro culture of bovine embryos.
The degree of development for compacted morula was based on the extent
cell membrane contact; with a degree of 4 exhibiting no contact and 1 complete cell
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Table 1. The Collins-Ryan Embryo Development (C-RED) score system
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Table 2. Examples of the Collins-Ryan Embryo Development (C-RED) score system

Hatched
blastocyst

smoothing. An early blastocyst was assigned to an embryo based on the presence
of a blastoceol that was not greater than 50% the volume of the embryo. A degree
of 4 was considered to have a cavitated while a degree of 1 had a blastoceol making
up 50% the volume of the embryo. If the blastoceol was greater than 50% the
volume of the embryo a blastocyst state was assigned. The expanded blastocyst
state fit any embryo whose blastoceol was the vast majority of the volume of the
embryo and there was evidence of zona pellucida thinning. A degree 3 hatching
blastocyst was assigned any embryo that exhibited signs of hatching with less than
50% of the embryo outside the zona pellucida. Likewise, a degree 2 hatching
blastocyst was considered to be any embryo greater than 50% hatched but not
completely free of zona pellucida. A degree 1 hatched blastocyst was any embryo
completely zona pellucida free.
The C-RED score can be described by the formula Yij = µ + φi + φj, where
Yij = the C-RED score for an embryos at the ith state of development and the jth
degree of development, µ = the overall mean C-RED score for the embryos, φi = Yi
– µi and φj = Yj – µj.
Embryo Diameter
At 128 hours pc, any embryo that had cavitated was photographed using a
Nikon TE-200 inverted microscope with 40X objectives and a Cannon SLR 35 mm
AEI camera using 400 ASA KodaChrome color slide film.
Following development of the film, the embryo images were scanned using
a color slide scanner (Microtek 35t) at 200 dpi. The embryo diameter (the mass of
blastomeres including the blastocoel, but exclusive of the perivitelline space and
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the zona pellucida) was determined using the measure tool of Adobe Photoshop 5.0
that had been calibrated with a stage micrometer. Measurements for each embryo
were taken on 3 axes and averaged to calculate the embryo diameter.
HPRT Microassay, Embryo Sex and Genotype Determination
Following photomicroscopy individual embryos were washed 3 times
through phosphate-buffered saline containing 4 mg/ml polyvinylpyrrolidone (PBSPVP). They were then individually transferred to 0.5-ml Eppendorf
microcentrifuge tubes with 12 µl of PBS-PVP solution and frozen at -70oC until
assay.
A 4-µl volume of the PBS-PVP solution was assayed for HPRT activity
using the method described by Downs and Dow (1991). The HPRT assay was
validated with a time course using three assays of 4-cell embryos at 3-hour
intervals for 12 hours. In addition, a standard curve was plotted with each assay
using known amounts of HPRT (hypoxanthine-guanine phosphoribosyl transferase,
Sigma, St. Louis, MO).
A 10-µl volume of lysis buffer (50 mM KCL, 10 mM Tris-Cl, pH 8.3,
0.45% Nonidet P-40 and 0.45% Tween 20) with 100 µg of proteinase K was added
to the remaining 8 µl of the embryo lysate and incubated at 55oC for 1 hour
followed by incubation at 99oC for 10 minutes.
PCR to determine the sex of the embryo was performed using 9 µl of the
above embryo sample as template. The PCR consisted of 1X PCR buffer, 200 µg
of dNTP’s (Gibco, Bethesda, MD), 2.5 units of Taq polymearse (Gibco), 150 mM
MgCl and 1,000 nM of each oligonucleotide primer described by Aansen and
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Medrano (1990) and designed to amplify a 450 base pair region of the mouse
ZFX/ZFY gene. The reactions were thermocycled in a PTC-150 minicycler (MJ
Research, Washington, DC). The thermocyler profile consisted of 5 minutes at
95oC; followed by 50 cycles of 1 minute at 95oC, 1 minute at 55oC and 1 minute at
72oC and a final 10 minutes at 72oC. Then 0.1 µl of this reaction was used as the
template in a subsequent PCR using primers mgc02-28-1b and 2b. The reaction
conditions were identical to that above, and the only alteration in thermocycling
parameters was the substitution of 35 cycles for 50 cycles. A 15-µl volume of the
resulting reaction was digested to completion with HaeII restriction endonuclease
in a 20-µl total volume at 37oC.
The remaining 9 µl of embryo sample was used as a template in a PCR with
primers, mgc02-10-3b and mgc02-10-4b, specific for the HPRT transgene. The
reaction conditions and thermocycle parameters were the same as above. Primer
sequences unique to this study are listed in Table 3.
The resulting sex determination and embryo genotyping products were
resolved in a 3% agarose gel (SeaKem, FMC, Portland, ME). The fragments were
visualized by ethidium bromide fluorescence using ultraviolet illumination.
The PCR assays were validated prior to embryo sex and genotype
determination by diluting known genomic DNA to a concentration of 12.5 pg/µl
and treating 8 µl of the genomic DNA similar to the embryo lysate above.
Genomic DNA samples of each sex and genotype were run with each assay to serve
as positive controls. Negative controls to detect contamination consisted of the
embryo lysis buffer without embryo or genomic DNA samples.
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234-253
410-429
1759-1778, 1548-1567
2012-2036, 1806-1825

HPRT cDNA
(Koneck et al., 1982)

Zfx,Zfy
(Mardon et al., 1990)
(Ashworth et al.,1999)

Template
squence

Nucleotide
position of
primers

5’-tgctcgagatgtcatgaagg-3’
5’-tatgtccccgttgactgat-3’

Primer
squences

mgc02-28-1b 5’-accaaccgaatgttgatgactg-3’
mgc02-28-2b 5’-tggcattcatagggattttc-3’

mgc01-34-1b
mgc01-34-2b

Primer
name

Table 3. Details of the primers used in the mouse embryo PCR sexing and genotyping assay
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196

Product
length (bp)

Experimental Design
This experiment was designed to determine if the HPRT transgene will alter
the sex and genotype ratios of mouse embryos. Therefore, any significant
deviation from the expected 25% male nontransgenic will be taken as an indication
of HPRT alteration of the sex and genotype ratios. A total of 34 mice were used
for RNA collection from the gonads, livers, hearts and brains.
Statistical Analysis
The deviation of sex and genotype from the expected was tested for
statistical significance by Chi-square analysis. An analysis of variance for repeated
measures was used to examine the effects of time and sex and genotype of the
embryos on the C-RED score. The correlation of sex and genotype with HPRT
activity was tested using a standard regression model. The relationship of HPRT
activity, sex and genotype with the embryo diameter was analyzed using a general
linear model. All statistical procedures were performed using version 8.0 of the
SAS software for windows (Stokes et al., 1995).
Results
Thirteen donors (5 mated to HPRT-A males and 8 to HPRT-B males)
yielded 282 embryos over 6 replicates. Of these embryos, 77.3% survived culture
to the 2-cell stage, 60.3% reached the 4-cell stage, resulting in 138 morulae. There
was no detectable difference in embryo development between lines. Of the 124
embryos surviving culture to the blastocyst stage, 51 were derived from line HPRTA and 73 from line HPRT-B. PCR data were collected on 105 of the 124
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blastocysts. PCR failure in all cases is attributed to sample loss prior to analysis
since all embryos failing to produce PCR products also failed to yield HPRT
activity. Only C-RED scores from embryos with known sex and genotypes were
used in the analysis.
Adult mice that were hemizygous for the transgene (Tg/-) were examined
for increased expression of HPRT versus nontransgenic littermates (+/+) (Figure
14). As expected, there were increased levels of HPRT mRNA in the organs
examined from the transgenic mice. However, female nontransgenic mice appear
to have greater amounts of HPRT mRNA in the heart tissue compared with the
heart tissue in the transgenic animals. Similarly, the males of HPRT-A showed
lower levels of HPRT mRNA in the brain tissue compared with the brain tissue of
the nontransgenic mice. Transgenic mice of both lines and sexes have increased
HPRT mRNA levels in the gonads. As with the increased mRNA levels, there was
a highly significant effect of sex and genotype on the HPRT activity of the embryos
(P<0.01), with the female transgenic embryos having mean HPRT activity of 2.63
pmol/hour/embryo compared with only 0.62 pmol/hour/embryo and 0.93
pmol/hour/embryo for the female nontransgenic and male transgenic embryos. As
expected, the male nontransgenic embryos had the lowest mean HPRT activity
(0.38 pmol/hour/embryo). The mean HPRT activity is presented in Figure 15.
Of the 105 embryos from which PCR sex and genotype data were collected,
68 (65%) were male and nontransgenic, 19 (18%) were male and transgenic, 13
(13%) were female and nontransgenic and 5 (5%) were female transgenic embryos.
This ratio of sex and genotype were significantly different from the expected
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Figure 14. Expression of HPRT mRNA in tissue of adult mice derived from both transgenic lines, HPRT-A
and HPRT-B (strains A and B, respectively) and nontransgenic FVB/N mice (strain W). The numbers on
the right refer to kilobases.
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Figure 15. The mean HPRT activity (±SE) of mouse blastocysts overexpressing
HPRT. Female transgenic (F/Tg), female nontransgenic (F/+), male transgenic
(M/Tg) and male nontransgenic (M/+). a,bBars with different superscripts are
significantly different (P<0.05).
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(P<0.05, χ2-test). The two mice lines (HPRT-A and HPRT-B) currently have a live
birth sex ratio of 53.1% and 47.6% males, respectively, and a genotype ratio of
47% and 44.8% positive, respectively.
The level of HPRT activity could not be correlated with the embryo
diameter (Figure 16). However, there was a significant effect (P<0.05) of sex on
embryo diameter. Male embryos had a larger mean diameter with 106.4 µ
compared with 98.4 µ for the female embryos.
There was a significant effect of embryo genotype and sex over time on the
assigned C-RED scores (P<0.05). Mean C-RED scores for embryos of different
sex and genotype are presented in Figure 17. There was no difference in C-RED
scores between embryo groups at 72 hours pc. At 80 to 96 hours pc female
transgenic embryos tended to plateau, while the embryo of the opposite sex and
genotype showed increased development. This produced a significant positive
effect of sex and genotype at 96 hours pc (P<0.01). However, by 104 hours pc the
lagging female transgenic embryos had increased from the previous C-RED score.
This trend continued until 112 hours pc, after which there was a decline in C-RED
score for female transgenic embryos producing a significant negative effect
(P<0.001) of sex and genotype at 128 hours pc.
Discussion
The sex ratio of, 83% male compared with 18% female, reported in this
study are supported by reports on other animals from other laboratories. Avery et
al. (1989) reported a significant difference in the development of bovine embryos at
the blastocyst stage. In this study, male embryos reached the blastocyst stage

60

120

b
a

Mean Embryo Diameter (µ)

100

80

60

40

20

0
Female

Male

Sex

Figure 16. The mean embryo diameter (±SE) of FVB/N mouse blastocysts
overexpressing HPRT. a,bBars with different superscripts are significantly different
(P<0.05).
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(F/+), male transgenic (M/Tg) and male nontransgenic (M/+).
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before female embryos. The presence of the Y-chromosome in male embryos was
considered to be responsible for the faster rate of development. Similar findings
were later reported by the same group, again with bovine embryos (Avery et al.,
1991).
Valdivia et al. (1993), studying the sex differences of mouse embryos,
determined that male embryos formed a blastocoel before female embryos. This
was attributed to the activity of two X-chromosomes of female embryos. Male
mouse embryos had a greater rate of cleavage than female mouse embryos in a
study by Peippo and Bredbacka (1995). Tusonda et al. (1995), also working with
mouse embryos, detected an alteration in the rate of blastomeres cleavage between
male and female embryos. Similar results were noted by Cassar et al. (1994) while
studying pig embryos. In that study an alteration between male and female pig
embryos was reported in the rate of growth, before and after hatching. Xu et al.
(1992) also showed a difference in development rates of bovine embryos. Male
bovine embryos developed faster than female bovine embryos in the latter report.
Konecki et al. (1982) isolated the mouse HPRT cDNA and reported that the
mRNA was 1,292 base pairs in length. There is a 87 base pair 5’ noncoding region
situated upstream of the 657 base pair open reading frame. The open reading frame
precedes a 548 base pair 3’ noncoding sequence. There are two polyadenylation
signals overlapping in the 3’ noncoding sequence. An additional polyadenylation
signal is present. The HPRT mRNA codes for a 218 amino acid protein. In all
animals studied thus far the protein is highly conserved (Jiralerspong and Patel,
1996).
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As expected, in the present study there was increased HPRT mRNA levels
were detected in the brain, liver and gonads of mice overexpressing HPRT. Higher
levels of HPRT mRNA from the HPRT promoter were found in the heart.
However, the HPRT microassay demonstrates that the embryos positive for the
HPRT transgene have increased levels of HPRT activity compared with the control
embryos of the same sex. This validates the mouse embryos used in this study as a
model of the effects of overexpression of HPRT in preimplantation mouse
embryos.
This is the first report of a genotype ratio for a HPRT transgene in mouse
blastocysts. The genotype ratio of 78% nontransgenic compared with 22%
transgenic indicates that HPRT is involved in the sexual dimorphism of mouse
embryos. Other studies have implied that HPRT may be involved in the altered sex
ratios of both murine and bovine embryos (Peippo and Bredbacka, 1995;
Bredbacka and Bredbacka, 1996). Unlike the present study, the latter reports did
not provide direct experimental evidence that HPRT altered the sex ratio.
The C-RED score results indicate that embryos with higher HPRT activity
develop a blastocoel later than those embryos with lower HPRT activity. However,
this was only detected in the female transgenic embryos. The female transgenic
embryos have HPRT levels that are greater than the highest HPRT levels found in
embryos from nontransgenic mice (Kratzer, 1983). Therefore, the C-RED scores
could be revealing an effect of HPRT that is unique to the HPRT transgenic mouse
embryos.
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It was concluded by Jiralerspong and Patel (1996) that there was not an
apparent mechanism for HPRT involvement in blastoceol formation. Following
genomic activation and degradation of maternal RNA, it is possible that the
increased levels of purines in female embryos are converted more rapidly to GMP
by HPRT (Bachvarova and Deleon, 1980). This would lead to the creation of less
AMP via the adenosyl phosphoribosyl transferase (APRT) pathway due to the
accompanied decrease in phosphoribosyl pyrophosphate levels. This would result
in a decrease of ATP available in the presumptive trophectoderm for use by the
Na+/K+ ATPase for blastoceol expansion (Fleming, 1992).
The lack of effect of HPRT activity on embryo diameter while sex has an
influence demonstrates that sexual dimorphism of preimplantation embryos is
likely due to multiple gene products, not only to HPRT. In addition, this measure
is only reflective of the contribution of embryo diameter to the stage of embryo
development and the resulting sex related growth rates.
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OVEREXPRESSION OF THE HPRT GENE IN MOUSE EMBRYOS AND
THE NUMBER OF BLASTOMERES IN BLASTOOCYSTS
Introduction
Avery et al. (1989) determined that there was a disparity in growth rates
between male and female bovine embryos. In this report male embryos reached the
blastocyst stage faster than female embryos. This was attributed to the presence of
the Y-chromosome in male embryos. Avery et al. (1991) detected a faster
development of male bovine embryos to the blastocyst stage compared with female
embryos. The faster development of the male embryos was again attributed to the
Y-chromosome in the male embryos. Similarly, Avery et al. (1992) considered the
presence of the Y-chromosome to alter the growth of bovine embryos. In this
study, male embryos formed a blastocoel faster than female embryos.
Bredbacka and Bredbacka (1996) detected a faster development to the
blastocyst stage between male and female bovine embryos. The report suggested
that the presence of two X-chromosomes in the female embryos was the cause of
the altered rates of growth. Previously, Peippo and Bredbacka (1995) reported a
faster rate of blastomeres cleavage with mouse embryos. In this study, the male
mouse embryos increase the number of blastomeres at a faster rate than the female
embryos. This result was also attributed to the activity of two X-chromosomes in
the female embryos.
The disparity of growth between female and male embryos has been
expressed in different ways. Some studies compared the percentage of female to
male embryos reaching a particular stage of development of bovine embryos
(Avery et al., 1991; Avery et al., 1992; Callesen et al., 1995; Grisart et al., 1995).
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Other studies chose to ascertain the differences in morphological development
based on size or time of cavitation of bovine embryos (Carvalho et al., 1996;
Hochman et al., 1996). Further studies considered the increase in the number of
blastomeres as an indication of greater development of mouse embryos (Valdivia et
al., 1993; Peippo and Bredbacka, 1995).
Hypoxanthine phosphoribsyl transferase (HPRT) is an X-linked gene
(Konecki et al., 1982) that is responsible for the salvage of the purines,
hypoxanthine and guanine (Voet and Voet, 1990). HPRT is active in mouse
embryos (Monk and Kathuria, 1977). The level of HPRT activity is related to the
number of X-chromosomes present in mouse embryos prior to X-chromosome
inactivation (Monk and Harper, 1978). The level of HPRT activity in bovine
embryos has also been related to the number of X-chromosomes (Gutierrez-Adan
et al., 2000).
Downs (1997a) studied the effect of hypoxanthine on oocyte maturation of
mouse embryos. The results of this study determined that hypoxanthine is
responsible for arresting maturation of mouse embryos. The arrest of mouse oocyte
maturation by hypoxanthine can be overcome by the addition of cyclic-AMP
(Downs, 1997b).
Recently, Bredbacka (2001) hypothesized that HPRT is responsible for the
faster development of male mouse and cow embryos. This effect of HPRT is
attributed the detoxification of reactive oxygen species. This hypothesis is
supported with studies of bovine embryos by Gutierrez-Adan (2000).
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The present study utilizes constructed mouse lines overexpressing HPRT to
determine if HPRT has an effect on the cell number of mouse blastocysts. In
addition, to the cell number of blastocysts the embryo growth rates and embryo sex
ratios of the transgenic mouse lines will be evaluated.
Materials and Methods
Transgenic Mice
The lines HPRT-A and HPRT-B [TgN(HPRT)ARlm and TgN(HPRT)
BRlm, respectively] were derived by pronuclear microinjection of the HPRT
transgene at the Louisiana State University Pennington Biomedical Research
Center.
The HPRT transgene was constructed by excising the agouti fragment of the
PGK-agouti plasmid (Klebig et al.,1995) by using PstI digestion. The full length
mouse HPRT cDNA (Konecki et al., 1992) was ligated to the PGK plasmid and the
expression cassette removed by digestion with EcoRI-ApaI.
The HPRT transgene was suspended at a concentration of 3 ng/ml in TrisEDTA (pH 8.0) buffer. The HPRT transgene was injected into either the male or
female pronuclei of FVB/N mouse sperm-exposed ovum held in place by a ~50 µ
diameter holding pipette. An injection pipette (diameter of < 1 µ) was passed
through the zona pellucida, the vitelline membrane of the ovum and the pronuclear
membrane. The HPRT transgene (~3 pg) was then deposited in the pronucleus by
applying positive pressure until the pronucleus had enlarged by at least twice the
original size. The injection pipette was then removed from the ovum. All ova were
collected and incubated as described herein.

68

Transgene Expression
To confirm that the HPRT transgene was being transcribed in the mouse
embryos being studied, rt-PCR was performed on groups of ten 4-cell mouse
embryos using the procedures described by Collins et al. (1995), with primers
specific for the HPRT transgene.
Embryo Collection and Culture Conditions
Male mice hemizygous for the HPRT transgene were placed with female
mice immediately after administration of 5 IU of human chorionic gonadotropin
(Sigma, St. Louis MO). The female mice were administered 5 IU of equine
chorionic gonadotrpin (Sigma, St. Louis, MO) 48 hours prior to the 5 IU of human
chorionic gonadotropin. The male mice were derived from either the HPRT-A or
HPRT-B transgenic lines. Coitus was estimated to have occurred at 12:00 am.
Embryos were collected from the oviducts the following morning from females
exhibiting vaginal mucus plugs. Embryos obtained form the same lines were
pooled per replicate. This experiment had 5 replicates.
The embryos were collected by excising the oviducts from the female mice
that were sacrificed by cervical dislocation. The oviducts were placed into M16
medium (Sigma, St. Louis, MO) and the embryos removed from the oviducts by
excising the cumulus masses with watchmaker forceps and a 26-gauge needle. The
embryos were cultured in 100 µl of M16 medium for 24 hours. The embryos at this
point were transferred to 100 µl of M16 medium supplemented with 4 mg/ml of
bovine serum albumin (BSA Fraction-V, Sigma, St. Louis, MO). An embryo
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exhibiting signs of compaction 48 hours after embryo collection was transferred
individually into 35 µl of M16 medium with 4 mg/ml BSA. The medium was
changed 48 hours later. All culture was carried out in 5 % CO2 air and 37oC.
Embryo Scoring
Beginning 72 hours post-coitum (pc) embryos were assigned a CollinsRyan Embryo Development (C-RED) score. The C-RED was adapted from the
RED score developed by Ryan et al. (1992). The C-RED score consists of 20
scores ranging from 0.01 to 5.00 at intervals of 0.33. A score of 0.01 is a
degenerate embryo.
The scores from 0.33 to 1.00 are based on the degree of compaction of
morula. A score of 1.00 is an embryo exhibiting complete compaction. The scores
from 1.33 to 2.00 indicated the degree of blastocoel formation. A score of 2.00 is
assigned to an embryo with 50% of the volume of the embryo comprised of the
blastocoel. The scores from 2.33 to 3.00 are assigned to embryos based on a
blastocoel size greater than 50% the volume of the embryo without zona pellucida
thining. A score of 3.00 indicates a blastocoel that comprises the vast majority of
the embryo without zona pellucida thinning. The scores from 3.33 to 4.00 are
assigned based on evidence of zona pellucida thinning without hatching. A score
of 4.00 is assigned to an embryo with the greatest amount of zona pellucida
thinning prior to hatching. The scores from 4.33 to 5.00 are assigned based on the
degree of embryo hatching. A 4.33 score is assigned to an embryo less than 50%
outside the zona pellucida. A 4.66 score is assigned to an embryo more than 50%
outside the zona pellucida. A 5.00 score is assigned to an embryo completely zona
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pellucida free. The C-RED scores were assigned at 8-hour intervals until 128 hours
post-coitum.
Blastocyst Cell Number Determination
At 128 hours pc any embryo that had cavitated was stained with Hoechst
33345 (1 mg/ml for 5 minutes) and mounted on glass slides by air drying using the
method to flatten the embryo (Dyban, 1982). The embryos were then
photographed with a Cannon SLR 35 mm AE1 camera using 400 ASA
KodaChrome color slide film. The camera was attached to a Nikon TE 200
inverted microscope with a 40X objective. The embryos were illuminated with
ultraviolet light for photography.
Following development of the film the images of the embryo were projected
onto a dry erase board using a Kodak color slide projector situated 4.6 m from the
board. All visible cells were marked on the board and counted.
Embryo Sex and Genotype Determination
Following photomicroscopy individual embryos were recovered from the
slides by rehydrating with 8 µl of phosphate-buffered saline containing 4 mg/ml of
polyvinylpyrrolidone (PBS-PVP, Sigma, St. Louis, MO). They were then
individually transferred to 0.5-ml Eppendorf microcentrifuge tubes and frozen at
–70oC until assayed.
A 10-µl volume of lysis buffer (50 mM KCl, 10 mM Tris-Cl, pH 8.3, 0.45%
Nonidet P-40 and 0.45% Tween 20) with 100 µg of proteinase K was added to the
8 µl of the embryo lysate. The embryo lysated sample was then incubated at 55oC
for 1 hour followed by 99oC for 10 minutes.
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PCR to determine the sex of the embryo was performed on 9 µl of the
embryo sample using 1,000 nM of each oligonucleotide primer described by
Aansen and Medrano (1990) and designed to amplify a 450 base pair region of the
mouse ZFX/ZFY gene. The thermocycle profile consisted of 5 minutes at 95oC
followed by 50 cycles of 1 minute at 95oC, 1 minute at 55oC, and 1 minute at 72oC
and a final 10 minutes at 72oC. The PCR was performed using a 1X PCR buffer,
200 µg of dNTP’s (Gibco, Bethesda, MD), 2.5 units of Taq Polymerase (Gibco,
Bethesda, MD) and 150 mM of MgCl. Approximately 0.1 µl of this reaction was
used as the PCR template in a subsequent reaction. This reaction used primers
mgc02-28-1b and 2b. Using the same reaction conditions, as the previous reaction,
this reaction was thermocycled for 35 cycles. A 15-µl volume of the resulting
reaction was digested to completion with HaeII restriction endonuclease in a 20-µl
total volume at 37oC. A MJ Research PTC-150 minicycler was used for all PCR
reactions.
The remaining 9 µl of embryo sample was amplified with primers, mgc0210-3b and mgc02-10-4b, specific for the HPRT transgene using the reaction
conditions herein. A 3% agarose gel (SeaKem, FMC, Portland, ME) was used to
resolve the PCR sex determination and embryo genotyping products. The
fragments were visualized following ethidium bromide staining using ultraviolet
illumination.
The PCR assays were validated prior to embryo sex and genotype
determination with 12.5 pg/µl of genomic DNA treated the same as the 8 µl of
embryo lysate. Positive controls of genomic DNA were run with each assay.
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Negative controls of the embryo lysis buffer without embryo or genomic DNA
samples were run with each assay. PCR failure was most often attributed to sample
loss or damage from the recovery technique.
Statistical Analysis
The deviation of sex and genotype from the expected was tested for
statistical significance by Chi-square analysis (Bredbacka and Bredbacka, 1996).
An analysis of variance for repeated measures was used to examine the effects of
time and sex and genotype of the embryos on the C-RED score. The relationship
of sex and genotype and the embryo cell number was analyzed using a linear
regression model (Stokes et al., 1995). All statistical procedures were performed
using version 8.0 of the SAS (Cary, NC) software for windows.
Results
The objective of this study was to study the effect of increased expression
of HPRT in mouse embryos on the resulting cell number in each blastocyst. To
accomplish this, two mouse lines shown to overexpress HPRT were used in this
study.
To confirm that the HPRT transgene was being transcribed in mouse
embryos obtained from nontransgenic (+/+) females mated to males hemizygous
(Tg/+) for the HPRT transgene, rt-PCR was performed on groups of 4-cell mouse
embryos using primers specific for the HPRT transgene (Figure 18).
Donor females (n=13) produced a total of 312 embryos over 5 replicates.
There was no detectable difference between embryos obtained from lines HPRT-A
and HPRT-B. Of the 166 embryos surviving culture to the blastocyst stage, 105
were from females mated to line HPRT-A males and 61 were from females mated
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Figure 18. rt-PCR products from groups of ten 4-cell embryos derived from two
lines (HPRT-A, lane 6 and HPRT-B, lane 4) and liver total RNA from a mouse of
known genotype (lane 2). Lane 7 is the 100 bp ladder. Lanes 1, 3, 5 are rt-PCR
products from liver total RNA, HPRT-B embryos and HPRT-A embryos,
respectively, without reverse transcriptase. Numbers on the right refer to base
pairs.
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to HPRT-B males. There were 136 blastocysts were recovered from the slides for
sex and genotype determination, and the sex and genotype was determined for 70
of the blastocysts (Figure 19).
Of the 70 embryos, 5 (7%) were female and transgenic, 16 (22.5%) were
female nontransgenic, 18 (25.7%) were male transgenic and the remaining 31
(44.3%) were male and nontransgenic. These values were not significantly
different from the expected ratios (χ2 test).
There was not a significant difference between the mean number of cells in
male and female blastocysts (72.8 and 75.1, respectively). The embryos with
positive PCR results for the HPRT transgene had 80.9±4.6 cells/blastocyst
compared with 69.9±3.6 cells/blastocyst for the embryos lacking the HPRT
transgene (Figure 20).
The C-RED scores are shown in Figure 21. There was not a significant
difference in the C-RED score profiles of the embryo groups. However, those
embryos that were female and transgenic tended to plateau between 80 and 88
hours pc. This was followed by a slight decrease in developmental rate at 112
hours pc with a compensatory increase from 112 to 120 hours pc. This can be
compared with the female nontransgenic embryos and the male transgenic and
nontransgenic embryos, where a steady increase in development from 80 to 120
hours was noted.
Disscussion
The HPRT gene is a highly conserved mammalian X-linked gene. In all
mammals studied the HPRT gene has greater than 95% homology (Jiralerspong and
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Figure 19. Example of PCR sex and genotype determination. A is PCR products from ZfX/ZfY gene. B is Ychromosome PCR product. C is X-chromosome PCR product after digestion with HaeII. D is PCR products from
the HPRT transgene. Numbers on the right refer to base pairs.
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Figure 20. The mean cell number/embryo (±SE) of FVB/N mouse blastocysts
overexpressing the HPRT transgene.
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mouse blastocysts overexpressing HPRT. Female transgenic (F/Tg), female
nontransgenic (F/+), male transgenic (M/Tg) and male nontransgenic (M/+).

78

Patel, 1996). The mouse HPRT gene is a 33 kilobase gene that is located on the
long arm (Xq26-q27) of the mouse X-chromosome (Shows and Brown, 1975). The
mouse HPRT gene has 9 exons (Shows and Brown, 1975).
The mouse HPRT mRNA is 1,292 base pairs long. There is a 657 base pair
open reading frame preceded by a 87 base pair 5’ noncoding sequence, and
followed by a 548 base pair 3’ noncoding sequence (Konecki et al., 1982). The 3’
noncoding sequence contains three polyadenylation signals. Two of the
polyadenylation signals are overlapping.
As expected there was HPRT transgene derived mRNA in 4-cell embryos
from nontransgenic females mated to transgenic males. This coupled with HPRT
activity in preimplanation mouse embryos of the two mouse lines (HPRT-A and
HPRT-B) overexpressing HPRT, confirm that the embryos used in this study have
increase HPRT mRNA levels and HPRT activity after embryonic genomic
activation.
Of concern is the failure to recover substantial PCR sex and genotype
information on the embryos used in this study. While 81.9% of the embryos were
recoverable from the slides, only 42.2% of the blastocysts could be reliably sexed
and genotyped. This failure is likely due to irreversible damage incurred during the
staining and photographing process. At present, an alternative to determining the
number of cells in the blastocysts was not available.
The low number of embryos producing PCR results may be a necessary
burden for obtaining the cell number of the blastocysts analyzed in this study and
categorizing them based on sex and genotype. While it was surprising to detect a
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significant effect of genotype on embryo cell number, it was more unexpected to
see a lack of effect of sex on cell number, since the previous studies with the same
transgenic lines found a difference in blastocyst size.
Peippo and Bredbacka (1995) detected a larger number of blastomere in
male mouse embryos. The HPRT gene was implicated in that study as the cause of
the greater number of cells in the male embryos. Similarly, Bredbacka and
Bredbacka (1996) found an increase in the number of cells in male bovine embryos
but indicated that this was due to the HPRT gene. Tusonda et al. (1995) detected a
greater rate of blastomere cleavage for male mouse embryos compared with female
mouse embryos. Similar results for mouse embryos were reported by Peippo and
Bredbacka (1995). The male mouse embryos had a greater rate of blastomere
formation than female mouse embryos in the latter study. In addition, Valdivia et
al. (1993) showed that male mouse embryos formed a blastocoel earlier than female
embryos. These studies attributed this difference to the activity of two Xchromosomes in the female embryos after genomic activation prior to Xchromosome inactivation.
Bredbacka and Bredbacka (1996) also attributed the faster development of
male bovine embryos to the presence of two X-chromosomes in female embryos.
However, Avery et al. (1989) attributed the faster development of male in vivoproduced bovine embryos to the blastocyst stage to the presence of the Ychromosome in the male embryos. This was followed by a report of faster
development of male bovine IVF-derived embryos to the blastocyst stage (Avery et
al., 1991), and this was also attributed to the activity of the Y-chromosome. Xu et
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al. (1992) showed a difference in the rate of growth of bovine embryos. This study
reported faster development of male embryos to the blastocyst stage. Cassar et al.
(1994) detected a faster rate of development for male pig embryos. This was
detected both before and after hatching. These studies agree with the sex ratio
(67% male: 33% female) found in this experiment with transgenic mouse embryos.
The results of this study indicate that overexpression of HPRT in
preimplantation mouse embryos alters the cell number of blastocysts, but does not
significantly alter the sex ratios or C-RED score profiles. This could be the effect
of too few embryos yielding PCR data in the present study.
This leads to the conclusion that HPRT is effecting preimplantation embryo
development of mouse embryos. Peippo and Bredbacka (1995) implied HPRT may
be one of the agents responsible for the deviant development of female compared
with male preimplantation embryos. It would be interesting to determine if the
same gene is also affecting the altered sex ratios of an economically valuable
species with a different placental type, such as the cow. Bredbacka and Bredbacka
(1996) indicated that HPRT was the gene that ultimately caused the faster
development of the male bovine embryos. In addition elucidation of the
mechanism of altered development rates may allow for greater control of in vitro
embryo development.
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THE EFFECT OF THE HYPOXANTHINE PHOSPHORIBOSYL
TRANSFERASE GENE IN CO-CULTURE OF MOUSE AND BOVINE
EMBRYOS
Introduction
Bredbacka and Bredbacka (1996) reported that male bovine embryos
developed faster to the blastocyst stage than female bovine embryos. This was
attributed to the activity of two hypoxanthine phosphoribosyl transferase (HPRT)
genes in female embryos (Bredbacka, 2001). Peippo and Bredbacka (1995)
detected a faster rate of blastomere cleavage for male mouse embryos compared
with female mouse embryos. The activity of two X-chromosomes in the female
embryo was implicated in the retarded development of the female mouse embryos.
Avery et al. (1989) have previously reported faster development of male
bovine embryos to the blastocyst stage than female bovine embryos. This was also
noted with bovine IVF-derived embryos (Avery et al., 1991). In these studies, the
presence of the Y-chromosome in male embryos is assumed to be responsible for
the faster development of the male embryos. Similarly, Avery et al. (1992)
considered the presence of the Y-chromosome in male bovine embryos to increase
their rate of growth compared with female bovine embryos. The male embryos in
this study formed a blastocoel faster than the female embryos.
The difference in growth of male and female embryos has been expressed in
various ways. Callesen et al. (1995) compared the percentage of male to female
bovine embryos at the blastocyst stage. In this study, there was a greater number of
male blastocyst than female blastocyst. Carvalho et al. (1996) and Hochman et al.
(1996) detected a difference in the time of blastocoel formation among male and
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female bovine embryos. The male embryos in these studies formed a blastocoel
earlier than the female embryos. Valdivia et al. (1993) considered the greater
increase in the number of blastomeres of male mouse embryos as an indication of
faster male development. Similarly, Peippo and Bredbacka (1995) detected a faster
rate of cleavage for male mouse embryos compared with female mouse embryos.
HPRT is an X-linked gene responsible for the salvage of purines (Konecki
et al., 1982). HPRT catalyzes the conversion of hypoxanthine and guanine to
inosine monophosphate (Konecki et al., 1982). In mouse and bovine embryos prior
to X-chromosome inactivation, the level of HPRT activity is related to the number
of X-chromosomes present in the embryos (Monk and Harper, 1978; GutierrezAdan et al., 2000).
Downs (1997a) studied the effect of hypoxanthine on mouse oocyte
maturation. This study and Downs (1997b) determined that hypoxanthine is
responsible for arresting maturation of mouse oocytes, and this effect of
hypoxanthine could be reversed by cyclic-AMP (Downs, 1997b).
Gutierrez-Adan (2000) hypothesized that HPRT is responsible for the faster
development of male bovine embryos. This was attributed to the detoxification of
reactive oxygen species by HPRT. This hypothesis was recently supported for
bovine embryos by Bredbacka (2001).
This study is designed to determine if the extra-embryonic level of HPRT
activity can effect the number of blastomere in mouse and cow embryos. This
study uses a cell line with the HPRT gene (Sanford et al., 1948) and a cell line
without the HPRT gene (Littlfield, 1963).
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Material and Methods
Mouse Embryos
Frozen B6D2F1 mouse embryos were obtained from Charles River
Laboratories and thawed according to the their instructions. Briefly, the straws
containing the sperm-exposed ovum were removed from the liquid nitrogen and
allowed to thaw at room temperature for 2 minutes. The contents of the straw were
mixed by shaking vigorously and then the straw was placed for 3 minutes in a 37oC
water bath with the sealed end of the straw exposed to the air. After 3 minutes the
straw was then incubated for 2 minutes in a room temperature water bath with the
plugged end of the straw exposed to the air. The contents were then expelled into a
35 mm Petri dish and allowed to stand at room temperature for an additional 2
minutes.
The embryos were then recovered and placed into a 50 µl of M16 medium
(Sigma, St. Louis, MO) under oil and incubated at 37oC with 5 % CO2 air for 48
hours. According to the commercial supplier the sperm-exposed ovum were frozen
at 10 hours post-copulation (copulation was considered to occur at 12:00 am
following injection of human chorionic gonadotrophin). The data reported herein
are based on the time of embryo thawing at this station.
Bovine Embryos
Bovine embryos were obtained from the basic in vitro maturation, in vitro
fertilization and in vitro culture procedure used in this laboratory (Zhang et al.,
1992). Mature bovine oocytes were used after collection from an abattoir by a
commercial supplier (Ovagenix, San Angelo, TX) and shipment overnight (22
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hours after oocyte collection) to the Louisiana State University, Embryo
Biotechnology Laboratory in St. Gabriel, Louisiana.
The bovine oocytes were matured at 37oC in M199 supplemented with 5%
fetal bovine serum (Sigma, St. Louis, MO). At 21 hours following oocyte
collection a 0.5-ml straw of bovine sperm (Holstein, #7H3694) was thawed by
placing it in a 37oC water bath for 1 minute, and the semen expelled into a sterile
15-ml centrifuge tube. To the 0.5 ml of semen 5.5 ml of Brackett-Oliphant medium
(Brackett and Oliphant, 1975) supplemented with 1 mg/ml of caffiene-sodium
benzonate (Sigma, St. Louis, MO) and 3.6 IU/ml of heperin sulfate (Sigma, St.
Louis, MO) was added. The sperm suspension was then centrifuged at 1,200 r.p.m.
with an H-10008 rotor and a Sorvall RT6000 centrifuge for 6 minutes. The
supernant was removed and the pellet was resuspended with 6 ml of the
supplemented Brackett-Oliphant medium, and again centrifuged for 6 minutes.
Following this second centrifugation, the supernant was removed and the
pellet was resuspended with 4 ml of the supplemented Bracket-Oliphant medium
and an additional 4 ml of Brackett-Oliphant medium supplemented with 6% fatty
acid-free bovine serum albumin (FAF-BSA, Sigma, St. Louis, MO) was added.
Then 500 µl (687,000 sperm) of this 8 ml sperm suspension was placed into each
well of a 4-well culture dish (1.5 cm diameter/well) and the dish was subsequently
placed at 39oC in 5 % CO2 air while the oocytes were washed.
The oocytes (200/replicate) with attached cumulus cells were washed by
removing the oocytes from the maturation medium and moving all 200 oocytes
through three 35 mm Petri dishes containing 2 ml of Bracket-Oliphant medium
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supplemented with 3% fatty acid-free bovine serum albumin. From the last dish,
50 oocytes were transferred with 50 µl of medium to one of the 500-µl sperm
suspension wells. The oocytes and sperm were then incubated at 39oC in 5% CO2
air for 5 hours.
After the 5 hours of incubation with the sperm, the oocytes were washed (as
a group 200/replicate) by sequential moving them through the 8 wells of two 4-well
dishes containing 400 µl of CR1aa medium (Rosenkrans and First, 1994)
supplemented with 5% fetal bovine serum and 10 µg/ml of insulin (human
recombinant, Sigma, St. Louis, MO). From the last well, 50 of the oocytes were
transferred with 50 µl of medium to a well of a 4-well dish containing 500 µl of the
supplemented CR1aa medium. When they were placed into the treatment groups
the resulting embryos were then incubated at 39oC in 5% CO2 air for 60 hours.
Cell Lines
Bovine cumulus cells were obtained by culturing 50 bovine embryos with
attached cumulus cells in a well of a 4-well dish with 500 µl of CR1aa medium,
supplemented as above for 5 days (the medium was changed once after 3 days) and
then removing the embryos from the resulting monolayer and detaching the cells by
exposure to 0.01% Trypsin-EDTA (Gibco, Bethesda, MD) for 5 minutes at room
temperature. The resulting cell suspension was placed into sequentially larger
culture vessels until the culture was maintained in a 25-mm culture flask
supplemented with CR1aa medium and subpassed every 3 days. Two separate
cultures derived in this fashion were used in this experiment and all the cells used
in this study were between fifth and tenth subpassages.
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Two cell lines, one with hypoxanthine phosphoribosyl transferase activity
(CCL-1.0) and one without hypoxanthine phosphoribosyl transferase activity
(CCL-1.4), were acquired from American Type Culture Collection (ATCC,
Rockville, MD), and are referred to here as HPRT-positive and HPRT-negative,
respectively.
The HPRT-positive cell line is a continous cell line that Sanford et al.
(1948) derived from a 100-day-old C3H/An mouse. The cells are derived from
adipose and areolar tissue. The HPRT-negative cell line was isolated from the
HPRT-positive cell line described by Littlefield (1963). The HPRT-negative cell
line is deficient in the HPRT gene. This deficiency makes the HPRT-negative cells
sensitive to HAT (hypoxanthine, aminopterin and thymidine) selection. The
sensitivity of the HPRT-negative and the insensitivity of the HPRT-positive cell
lines to HAT selection was determined prior to this experiment. This was
performed by culturing for 3 days in the presence of HAT selection (data not
shown).
The HPRT-positive and HPRT-negative cell lines were maintained in 75
cm2 tissue culture flasks (Falcon, Sigma, St. Louis, MO). The cells were
maintained with Dublecco’s Modified Eagle’s Medium (DMEM, Gibco, Bethesda,
MD) supplemented with 5% fetal bovine serum at 37oC in an atmosphere of 5%
CO2. The cultures were subpassaged at 3-day intervals.
Experimental Design
Starting 24 hours before the start of the experiment, one well of a 4-well
dish was seeded with 10,000 cells from one of the three cell lines mentioned
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previously. The cells were then incubated in 500 µl of the supplemented CR1aa
medium overnight.
For the mouse embryos, any embryo that exhibited evidence of compaction
48 hours after thawing was placed into co-culture, with one of the three cell lines,
in CR1aa medium until 118 hours after thawing. At this time, a Collins-Ryan
Embryo Development (C-RED) score was assigned at 8-hour intervals for each
embryo beginning 56 hours post-thaw. The mean score for each treatment well
was determined by averaging the scores of all the embryos in each well at each
time point. The medium was changed twice during culture.
At 118 hours post-thaw, any embryo that had cavitated was stained with
Hoechst 33345 (1 mg/ml for 5 minutes). The embryos were mounted on glass
slides using the method to flatten the embryo (Dyban, 1982). Embryo photographs
were made with a Nikon inverted Diaphot microscope with 40X objectives and a
Cannon SLR 35mm AE1 camera. The film used was 400 ASA KodaChrome color
slide film. The embryos were photographed with ultraviolet illumination. The
images of the embryos were projected onto a dry erase board and all visible cells
were marked on the board and counted. The images were projected with a Kodak
color slide projector situated 4.6 m from the board. This experiment contains 5
replicates with 20 embryos/treatment.
After the bovine embryos were incubated for 60 hours post-insemination,
the cumulus cells were stripped off the embryos by vigorously pipetting them with
a pulled Pasteur pipette of ~180 µ in diameter until all the cumulus cells were
detached. Any embryo that had 4 or more cells was then randomly placed into 1 of
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3 wells of a 4-well culture dish containing 1 of the cell lines mentioned earlier for
co-culture. The embryos were cultured until 192 hours post-insemination at which
time any embryo that had cavitated was stained with Hoechst 33345 (1 mg/ml for 5
minutes). Using the air drying method reported by Dyban (1982), the embryos
were mounted on glass slides and flattened. The embryos were then photographed
using a Nikon inverted Diaphot microscope with 10X objectives. The embryos
were illuminated with ultraviolet light. Photographs were made with a Cannon SLR
35mm AE1 camera using 400 ASA KodaChrome color slide film. Using a Kodak
color slide projector the images, after development of the film, were projected onto
a dry erase board 4.6 m from the projector. All visible cells were marked and
counted. This experiment had 5 replicates.
Results
Mouse Embryos
There was not a significant difference in the number of mouse blastocyst
and hatched blastocysts between treatment groups (Table 4; P>0.05). Of the one
hundred 8-cell embryos co-cultured with the HPRT-positive cell line, 82 developed
blastocoels and 6 embryos hatched. Similarly, of the one hundred 8-cell embryos
co-cultured with the HPRT-negative cell line 75 embryos developed blastocoels
and 6 hatched. This can be compared with the one hundred 8-cell embryos cocultured with the bovine cumulus cells. Of these, 76 developed blastocoels and 8
embryos hatched.
There was, however, a significant difference in the number of blastomeres
contained in each blastocyst (Figure 22). There were significantly more
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HPRT negative

*

Following 5 days of culture.

100

100

HPRT positive

Bovine cumulus

No. of 8-cell embryos

Co-culture
cells

76 (76)

75 (75)

82 (82)

Blastocysts (%)

8 (8)

6 (6)

6 (6)

Hatched blastocysts (%)*

Table 4. The development of mouse embryos co-cultured with HPRT-positive mouse cells,
HPRT-negative mouse cells and bovine cumulus cells

blastomeres (±SE) (78.5±8.86) in the blastocysts that were co-cultured with the
cells containing the hypoxanthine phosphoribosyl transferase gene than in the
blastocysts co-cultured with bovine cumulus cells (59.5±5.78) and those cocultured with cells missing the hypoxanthine phosphoribosyl transferase gene
(64.0±3.1) (P<0.05).
There was not a significant difference between the developmental rates of
the embyos co-cultured with the HPRT-positive, HPRT-negative and bovine
cumulus cells, as indicated by the C-RED scores (Figure 23).
Bovine Embryos
There was a detectable difference in the rate of development to blastocyst
from the 8-cell stage (Table 5). There were significantly (P<0.05) fewer
blastocysts (31.2%) in the group of embryos cultured with bovine cumulus cells
than the group cultured with the cells missing the hypoxanthine phosphoribosyl
transferase gene (43.2%). There was no detectable difference between the number
of blastocysts obtained from co-culturing the embryos with the HPRT-positive cells
and those co-cultured with HPRT-negative cells (41.8% and 43.2%, respectively).
In addition, there was no significant difference in the number of blastocyst hatching
between the treatment groups. The embryos co-cultured with the HPRT-positive
cells, HPRT-negative cells and bovine cumulus cells with 8.1, 8.8 and 7.0% of the
embryos hatching, respectively.
Also, there was not a significant difference in the number of blastomeres
regardless of the culture treatment groups. There were 191±10.1 cells/blastocyst
co-cultured with the cells containing the hypoxanthine phosphoribosyl transferase
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Figure 22. The mean embryo cell number (±SE) for mouse blastocysts co-cultured
with HPRT-positive, HPRT-negative and bovine cumulus cells. a,bBars with
different superscripts are significantly different (P<0.05).
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Figure 23. The mean Collins-Ryan Embryo Development (C-RED) scores of
mouse blastocysts co-cultured with HPRT-positive, HPRT-negative and bovine
cumulus cells.
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Table 5. The development of bovine embryos co-cultured with HPRT-positive mouse cells, HPRTnegative mouse cells and bovine cumulus cells

gene compared with 200±7.3 cells/blastocyst co-cultured with the cells missing the
hypoxanthine phosphoribosyl transferase gene and 195±6.8 cells/blastocyst cocultured with the bovine cumulus cells (Figure 24).
Discussion
In the present study the larger number of blastomeres in the mouse embryos
co-cultured with the HPRT-positive cells is supported Peippo and Bredbacka
(1995), who showed that male mouse embryos have a faster rate of blastomere
cleavage than do female mouse embryos. The latter report suggested that the
HPRT gene was the factor causing the accelerated male embryo growth. The same
effect of sex on the rate of blastomere cleavage with mouse embryos has been
reported by Tusonda et al. (1995). They noted that male mouse embryos had an
increased number of blastomeres compared with female embryos. Similarly,
Valdivia et al. (1993) detected an increase rate of blastocoel formation with mouse
embryos. The male embryos in this study formed blastocoels earlier than the
female embryos.
Cassar et al. (1994) reported an alteration in the rate of growth, before and
after hatching, between male and female pig embryos. Xu et al. (1992) showed that
male bovine embryos developed faster than female bovine embryos. This study
based development on the time of in vitro blastocoel formation. Avery et al. (1989)
used bovine in vivo-derived embryos determined that there was a significant effect
of sex on embryo development. The male embryos in the latter study reached the
blastocyst stage at a faster rate than the female embryos. The same group working
with bovine IVF-derived embryos detected a faster development to the blastocyst
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Figure 24. The mean cell number (±SE) of bovine blastocysts co-cultured with
HPRT-positive, HPRT-negative and bovine cumulus cells.
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stage by the male embryos (Avery et al., 1991). Among the bovine embryos
produced in a subsquent study (Avery et al., 1992), a greater number of males
developed blastocoel cavities.
The presence of the Y-chromosome in the male embryos has been proposed
in several studies to be the cause of the accelerated male embryo development
(Avery et al., 1989; Avery et al., 1991; Avery et al., 1992). Other groups have
proposed the presence of two X-chromosomes in the female embryos as the cause
of the hindered female embryo growth (Valdivia et al., 1993; Peippo and
Bredbacka, 1995; Bredbacka and Bredbacka, 1996; Bredbacka, 2001).
Peippo and Bredbacka (1996) indicated the HPRT gene was responsible for
the faster growth of male bovine embryos. Similarly, the HPRT gene has been
implicated in the altered rate of growth of male and female bovine embryos
(Bredbacka and Bredbacka, 1996). Gutierrez-Adan et al. (2000) suggested that
HPRT could be altering the rate of bovine embryo growth through the
concentration of reactive oxygen species in the embryo. This HPRT hypothesis
was further supported by Bredbacka (2001). This is, however, not supported by the
results of the present experiment. An effect of the HPRT cell lines was not
detected. The rate of blastocoel formation and blastocyst hatching was not
significantly different for the embryos co-cultured with the HPRT-positive cells
compared with the embryos co-cultured with the HPRT-negative cells However,
this experiment did not determine the effect of HPRT in the co-culture medium
alone.
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A significantly greater number of bovine embryos co-cultured with the
HPRT-negative cells developed blastocoels compared with those embryos cocultured with bovine cumulus cells. The blatoceol formation rate of the embryos
co-cultured with the HPRT-positive cells was not significantly different from the
embryos co-cultured with the HPRT-neagtive cells or the bovine cumulus cells.
These results could be a manifestation of the culture conditions required by the
cumulus cells compared with the specialized treatment cells. Normal culture of the
HPRT-positive and HPRT-negative cells requires minimal medium components
(DMEM) while bovine cumulus cell cultures likely require more medium
components (CR1aa medium).
The CR1aa medium, unlike DMEM, contains all essential and nonessential
amino acids (Rosenkrans and First, 1994). The greater requirements of the
cumulus cells could result in a reduced availability of nutrients for the embryos
when co-cultured with the cumulus cells compared with the less demanding
established cell lines used in the treatments, thus resulting in a decreased number of
embryos developing a blastocoel cavity.
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THE EFFECT OF HYPOXANTHINE PHOSPHORIBOSYL
TRANSFERASE INHIBITORS ON BOVINE EMBRYO DIAMETER AND
SEX RATIOS
Introduction
Bredbacka and Bredbacka (1996) reported that male bovine embryos
develop faster to the blastocyst stage than corresponding female embryos. This
supported previous work by the same group with mouse embryos (Peippo and
Bredbacka, 1995). In this study, the male mouse embryos had a greater increase in
blastomere number than the female precompaction embryos. The presence of two
X-linked hypoxanthine phosphoribosyl transferase (HPRT) genes in the female
embryos was implicated as the agent of delayed female embryo growth in both of
these studies. This involvement of HPRT in the faster development of male
embryos has recently been supported using bovine embryos by Guiterrez-Adan et
al. (2000).
Similar disparity of growth between male and female embryos was
previously reported by Avery et al. (1989). In this study, male bovine embryos
reached the blastocyst stage faster than female embryos. However, unlike the
findings of Bredbacka and Bredbacka (1996), the presence of the Y-chromosome in
the male embryos was considered the factor effecting the growth rates of the male
embryos. This finding was further supported by Avery et al. (1991) when it was
determined that male bovine embryos formed a blastocoel faster than female
embryos. The Y-chromosome was again implicated by Avery et al. (1992) in a
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study comparing the growth rates of sexed bovine embryos. Male embryos in this
study reached the blastocyst stage prior to female embryos.
The difference in growth of male and female embryos has been reported in
various different ways. Callesen et al. (1995) chose to compare the percentages of
bovine embryos developing to the blastocyst stage. This approach has been
employed by other groups studying bovine embryos, including Avery et al. (1991,
1992) and Grisart et al. (1995). Another method used by Carvalho et al. (1996),
was to determine the difference in bovine embryo diameter or time of blastocoel
development. Hochman et al. (1996) also used the percentage of bovine embryos
developing to the blastocyst stage as an indication of differential growth. Other
studies have reported an increase in the number of blastomeres as an indication of
greater development of mouse embryos (Valdivia et al., 1993; Peippo and
Bredbacka, 1995).
HPRT an X-linked gene is responsible for the salvage of hypoxanthine and
guanine (Konecki et al., 1982). Hypoxanthine and guanine are products of purine
degradation. The mouse HPRT gene has more than 95% homology with other
HPRT genes studied up to this time (Jiralerspong et al., 1996). The 657 base pair
open reading frame of the mouse 1,292 base pair HPRT mRNA encodes a 218
amino acid protein (Konecki et al., 1982; Jiralerspong et al., 1996). The level of
HPRT activity has been related to the number of X-chromosomes in mouse (Monk
and Harper, 1978) and bovine embryos (Gutierrez-Adan et al., 2000) prior to Xchromosome inactivation.
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Hypoxanthine was found to be responsible for the arrest of mouse oocyte
maturation, reported by Downs (1997a). Further work by Downs (1997b)
concluded that the addition of cyclic-AMP would allow the mouse oocytes to
continue the maturation process.
Both 6-azauridine and 6-mercaptopurine are purine analogs that decrease
hypoxanthine phosphoribosyl transferase activity in mammalian gametes and
embryos (Downs and Dow, 1991). HPRT activity can be increased by the addition
of the HPRT substrate hypoxanthine (Jiralerspong et al., 1996). Intracellular
hypoxanthine increases glucose transport in mouse embryos (Monk and Kathuria,
1977).
Materials and Methods
Bovine Embryos
Bovine IVF-derived embryos were obtained using the basic procedures
described by Zhang et al. (1992). Briefly, a straw of frozen sperm (Holstein
#7H3694) was thawed by placing the 0.5-ml straw in a 37oC water bath for
1 minute. The semen was then placed into 5.5 ml of Brackett-Oliphant medium
(Brackett and Oliphant, 1975) supplemented with 1 mg/ml of caffeine-sodium
benzonate (Sigma, St. Louis, MO). In addition the Brackett-Oliphant medium was
supplemented with 3.6 IU/ml of heparin sulfate (Sigma, St. Louis, MO). This
sperm suspension was centrifuged at 1,200 r.p.m. in an H-10008 rotor with a
Sorvall RT6000 centrifuge for 6 minutes.
Following removal of the supernant and suspension of the pellet in 6 ml of
the supplemented Brackett-Oliphant medium the sperm suspension was centrifuged
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for an additional 6 minutes. The sperm was then resuspended in 4 ml of the
supplemented Brackett-Oliphant medium and an additional 4 ml of BrackettOliphant medium supplemented with 6% fatty acid-free bovine serum albumin
(Sigma, St. Louis, MO). From this sperm suspension, 500 µl (~687,000 sperm)
was added to each well of a 4-well culture dish (1.5 cm diameter/well). The dish
was placed in a incubator at 39oC and 5% CO2 in air until the addition of the
oocyctes.
Oocytes (200/replicate) were obtained from a commercial supplier
(Ovagenix, San Angelo, TX) after collection from an abattoir and shipment to the
Louisiana State University, Embryo Biotechnology Laboratory in St. Gabriel,
Louisiana. The oocytes were shipped in maturation medium (M-199 supplemented
with 5% fetal bovine serum; Sigma, St. Louis, MO) at 37oC. The oocytes and
attached cumulus cells were washed by moving all 200 oocytes through three
consecutive 35 mm culture dishes containing 2 ml of Brackett-Oliphant medium
supplement with 3% fatty acid-free bovine serum albumin. From the last of the
washing dishes, 50 oocytes were placed into each of the 500-µl sperm suspensions
prepared above. The oocytes and sperm were then incubated at 39oC and 5% CO2
in air for 5 hours.
Following the 5 hours of incubation as a group, the oocytes were washed
(200/replicate) with CR1aa medium (Rosenkrans and First, 1994) supplemented
with 5% fetal bovine serum and 10 µg/ml of insulin (human recombinant; Sigma,
St. Louis, MO). This was done by sequentially moving them through the 8 wells of
two 4-well dishes containing 400 µl of the CR1aa medium (Rosenkrans and First,
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1994). To each well of a 4-well dish (containing 500 µl of the supplemented
CR1aa medium), 25 of the embryos were transferred along with 50 µl of medium.
The embryos were incubated at 39oC with 5% CO2 in air for 60 hours when
the embryos were stripped of the cumulus cells. This was performed by vigorously
pipetting them with a pulled Pasteur pipette of ~180 µ diameter until all the
cumulus cells were detached. Any embryo that had 4 or more blastomeres was
randomly aliquoted into each well of two 4-well dishes, and cultured an additional
48 hours in the supplemented CR1aa medium.
At that time point, 108 hours post-fertilization the medium was changed and
supplemented with either 1 mM 6-azauridine (Sigma, St. Louis, MO), 1 mM 6mercaptopurine (Sigma, St. Louis, MO), 1 mM hypoxanthine (Sigma, St. Louis,
MO) or water. Each well in one of the 4-well dishes was then supplemented with
5.5 mM glucose (Sigma, St. Louis, MO). The embryos remained in culture until
192 hours post-fertilization, when the embryos from each treatment group were
placed individually into 30-µl drops of M2 medium (Sigma, St. Louis, MO) and
covered with mineral oil.
Embryo Diameter
The embryos were photographed with a Nikon inverted Diaphot microscope
and 10X objectives using a Cannon SLR 35 mm AE1 camera. The film was 400
ASA KodaChrome color slide film. Following development of the film the images
were digitized using a Microtek 35t color slide scanner set at 200 dpi resolution. A
stage micrometer was used to calibrate the measure tool of Adobe Photoshop 5.0.
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The measure tool was then used to determine the mean diameter from 3 measured
axes.
Embryo Sex Determination
Following photomicroscopy individual embryos were washed 3 times
through PBS containing 4 mg/ml of polyvinylpyrrolidone (PBS-PVP, Sigma, St.
Louis, MO). The embryos were transferred to 0.5-ml Eppendorf microcentrifuge
tubes with 2 µl of PBS-PVP solution and frozen at –70oC until the sex
determination procedure.
Prior to the sex determination assay, 10 µl of lysis buffer (50 mM KCl, 10
mM Tris-Cl (pH 8.3), 0.45% Nonidet P-40, 0.45% Tween 20; Sigma, St. Louis,
MO) with 10 µg of proteinase K was added to the 2 µl of each embryo sample.
The samples were then incubated at 55oC for 1 hour followed by 99oC for 10
minutes.
The PCR consisted of 1X PCR buffer, 200 µg dNTP’s (Gibco, Bethesda,
MD), 2.5 units of Taq Polymerase (Gibco, Bethesda, MD), 150 mM MgCl and
1,000 nM of each oligonucleotide primer (mgc04-64-1b: 5’ccaatacacagaggtcatggtggg-3’ and mgc04-64-2b: 5’-ggaagactatgcaggtagcaggtgc-3’)
designed to amplify a 194 base pair region of the bovine repeat Y-associated gene.
A minicycler (MJ Research PTC-150) was used for the reaction. The reactions
were incubated for 5 minutes at 95oC; followed by 35 cycles of 1 minute at 95oC, 1
minute at 55oC and 1 minute at 72oC, and a final 10 minutes at 72oC. The resulting
reaction products (15 µl) were resolved with a 4% agarose gel (SeaKem, FMC,
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Portland, ME). The fragments were visualized by fluorescence following staining
with ethidium bromide and exposure to ultraviolet light (270 to 280 nm).
Prior to embryo sex determination, the procedure was validated by diluting
known genomic DNA to a concentration of 12.5 pg/µl and treating 12 µl of the
same as the embryo lysate. Positive controls for each sex were run with each assay
using the genomic DNA. To detect contamination negative controls consisted of
the embryo lysis buffer without embryo or genomic DNA.
Statistical Analysis
The deviation of sex from the expected (1:1) was tested for statistical
significance by Chi-square analysis (Stokes et al., 1995). An analysis of variance
for repeated measures was used to examine the effects of treatment on the
development of the embryos. The correlation of sex with treatment was tested
using a regression model. The relationship of sex and treatment with the embryo
diameter was analyzed using a general linear model. All statistical procedures were
performed using version 8.0 of the SAS software for windows. This experiment
contained 6 replicates.
Results
There was a significant difference in the number of blastocysts obtained
from the embryos cultured with 6-azauridine (19.2% with glucose and 19.2%
without glucose) and 6-mercaptopurine (20.0% with glucose and 19.2% without
glucose) from the embryos exposed to hypoxanthine (36.6% with glucose and
40.0% without glucose) and control (32.5% with glucose and 41.3% without
glucose) embryos (Table 6).

105

106

120
120
120
121

-

-

6-Azauridine

6-Mercaptopurine

Hypoxanthine

Control

a,b

308
32.1

961
80.1

50 (41.3)b

48 (40.0)b

23 (19.2)a

23 (19.2)a

Means with different superscripts within the same column are significantly different (P<0.05).

Percent of oocytes

1,200

120

-

+

Control

Total

44 (36.6)b
120

39 (32.5)b

24 (20.0)a

120

-

+
+

6-Mercaptopurine
Hypoxanthine

23 (19.2)a

Blastocysts (%)

120

No. of 4-cell embryos

-

No. of oocytes

+

Glucose

6-Azauridine

Treatment

Table 6. The development of bovine embryos cultured in the presence or absence of increased
glucose with HPRT inhibitors and an inducer

The embryos cultured in the presence of hypoxanthine and glucose had a
significant larger diameter (390±24.8 µ) than those exposed to the hypoxanthine
phosphoribosyl transferase inhibitors (6-Azauridine; 348±19.3 µ without glucose,
348±30.1 µ with glucose and 6-mercaptopurine; 333±20.7 µ without glucose,
313±12.9 µ with glucose). These were also significantly different than the diameter
of the control embryos (333±30.2 µ without glucose and 324±24.7 µ with glucose)
(Figure 25).
There was not a significant difference between the diameter of male and
female embryos, with the male embryos having a mean diameter of 347±13.9 µ and
the female embryos having a mean diameter of 345±12.3 µ (Figure 26). Similarly,
there was not a significant effect of sex and exposure to glucose on the mean
embryo diameter (Figure 27). The male embryos, with exposure to glucose had a
mean diameter of 364±23.1 µ and those without exposure to glucose had a mean
diameter of 333±16.7 µ. This can be compared with the female embryos, with those
exposed to glucose having a mean diameter of 343±16.5 µ and those without an
exposure to glucose having a mean diameter of 348±18.8 µ.
There was, a significant difference, however, in the mean diameters of the
male embryos cultured in hypoxanthine (374±23.5 µ) and 6-azauridine (384±36.0
µ) from the male control embryos (304±24.7 µ) and the female embryos cultured
with 6-mercaptopurine (317±13.8 µ) (Figure 28)
Glucose did not have a significant effect on the sex ratio of the blastocysts
regardless of the treatment groups. However, there was a significant difference
from the expected 1:1 ratio detected in the two hypoxanthine phosphoribosyl
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Figure 25. The mean diameter (±SE) of bovine blastocysts cultured in the
presence or absence of 5.5 mM glucose.
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Figure 26. The mean diameter (±SE) of male and female bovine blastocysts.
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Figure 27. The mean diameter (±SE) of male and female bovine blastocysts
co-cultured in the presence and absence of 5.5 mM glucose (Glu).
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Figure 28. The effect of sex and treatment on the mean diameter (±SE) of bovine
blastocysts. 6-azauridine (6-Aza), 6-mercaptopurine (6-Mp), hypoxanthine (Hx)
and control (Con). a,b Bars with different superscripts are significantly different
(P<0.05).
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transferase inhibitor groups and the control group (Table 7). The 50% females
detected in the group of embryos exposed to hypoxanthine was significantly less
than the 59.2, 75.0 and 64.3% females in the 6-azauridine, 6-mercaptopurine and
control groups, respectively.
Discussion
Faster development of male bovine embryos to the blastocyst stage has been
reported by Avery et al. (1989). Avery et al. (1989) considered the faster rate of
male embryo development to be the consequence of the Y-chromosome in the male
embryos. In further work by Avery et al. (1991) there was a greater number of
male bovine blastocyst developed in vitro compared with female blastocysts.
Valdivia et al. (1993) considered that the presence of two X-chromosomes
in female mouse embryos was delaying the development to the blastocyst stage
compared with male mouse embryos. The same conclusions with mouse embryos
were reported by Tusonda et al. (1992). The male mouse embryos in the latter
study developed faster than the female embryos. The two X-chromosomes in
female pig embryos was also considered by Cassar et al. (1994) to be the cause of
the delayed female embryonic development when compared with the male
embryos. In the latter study, an alteration in the rate of growth before and after
hatching was detected. These studies are supported by the observations of Xu et al.
(1992) indicating that slower development of female bovine embryos was
attributed to the activity of the X-chromosomes.
Bredbacka and Bredbacka (1996) considered that the delayed development
of female bovine embryos was due to the double dose of X-chromosome gene
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Table 7. The sex ratio of bovine embryos cultured with HPRT inhibitors and an inducer

products. Specifically, Bredbacka and Bredbacka (1996) implicated the HPRT
gene as the agent of delayed female embryo growth. This supported the results of
an earlier study by the same group with mouse embryos (Peippo and Bredbacka,
1995). Gutierrez-Adan et al. (2000) also implicated the HPRT gene as the cause of
the differences in growth of male and female bovine embryos. However, Peippo et
al. (2001) concluded that the faster cleavage rate for male bovine embryos was due
to the presence of glucose. Furthermore, in the absence of glucose female embryos
had a faster cleavage rate than the male embryos. The latter study did not address
the effect of sex on compaction and blastocoel formation.
Both 6-mercaptopurine and 6-azauridine have been used to decrease HPRT
activity in mouse gametes and embryos (Downs, 1997a). In addition, hypoxanthine
has been used to increase HPRT activity in mouse embryos (Downs and Dow,
1991). Hypoxanthine, in the concentrations used here, is known to be nontoxic to
mammalian cells and embryos (Down and Dow, 1991).
In the current study, glucose with hypoxanthine tended to delay
development to the blastocyst stage. This is not surprising since glucose is not
required for embryo development and may, to some extent, be embryo toxic (Davis
and Day, 1978; Menezo and Khatchadourian, 1990; Gardner and Lane, 1993). This
can be explained by hypoxanthine conversion to inosine monophosphate by HPRT.
This would expend more phosphoribosyl pyrophosphate and allow the shunting of
glucose into the pentose phosphate pathway (Fisher and Reicherter, 1984). This
would effectively lower the concentration of glucose preventing the detrimental
effects of its presence in the culture medium.
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The finding that embryos cultured in the presence of hypoxanthine and
glucose had larger diameters than the control embryos could also be explained by
the utilization of glucose to produce phosphoribosyl pyrophosphate. However, an
effect of hypoxanthine alone can not be ruled out (Peippo et al. 2001).
It was surprising that there was not a difference between the mean diameters
of the male and female bovine blastocysts in the present study. It must be kept in
mind that embryo diameter is only one parameter of embryo development, and
other studies have reported an increase rate of male bovine embryo development
without an increase in embryos diameter (Bredbacka and Bredbacka, 1996; Peippo
et al., 2001).
As expected, there was a deviation from the expected 1:1 ratio of male to
female embryos in the control groups regardless of the glucose concentration in the
control groups in this study. Unexpectedly, there were a higher percentage of
females in these groups. This is contrary to previous reports with bovine (Avery et
al., 1991), murine (Peippo and Bredbacka, 1995) and human (Tarin et al., 1995)
embryos, but is not different to a previous report from this laboratory with bovine
embryos (Collins, 1997). This may indicate an effect of the sex determination
procedure or the in vitro fertilization and culture system used to produce the
blastocyst. The sex determination methods used here have been validated with
genomic controls, both prior to and during the course of these experiments.
The concentrations of hypoxanthine used in this study tended to abolish the
skewed sex ratios. This result coupled with the nontoxicity of hypoxanthine, will
have implications, especially in the field of human in vitro fertilization, where it is
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desirable to culture IVF-derived embryos to the blastocyst stage to avoid multiple
pregnancies with unaltered live birth sex ratios (Tarin et al., 1995).
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CONCLUSIONS
The first experiment did not reveal any significant differences in the ability
of hypoxanthine phosphoribosyl transferase to protect cells from damage by
reactive oxygen species. Also, there was no major differences in the growth and
cell diameter of the two cell lines (HPRT-postive and HPRT-negative). These
results, however, are important since the further use of these cells as a model of
extra-embryonic HPRT activity will not be hampered by any extraneous factor,
such as cell growth.
Mouse embryos transgenic for the HPRT gene were used in the second
experiment. A deviation of the sex and genotype ratios from the expected 1:1
indicated that the HPRT gene is a factor effecting the development of
preimplantation mouse embryos. HPRT did not have an effect on the diameter of
the embryos. This indicates that the sexual dimorphism of preimplantation mouse
embryos is due to the action of numerous genes, which may and may not be sex
related.
A relationship was revealed in the third experiment between the number of
blastomeres in mouse blastocysts and the HPRT transgene. Mouse embryos
overexpressing HPRT had a greater number of blastomeres than embryos without
the HPRT transgene. The sex of the mouse embryos did not have an effect on the
number of cells in the blastocysts.
In the fourth experiment, HPRT was shown to affect the cell number of
mouse blastocysts in an extra-embryonic fashion. The mouse embryos co-cultured
with the HPRT-postive cells had more blastomeres at the blastocyst stage than
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those embryos co-cultured with bovine cumulus cells. The mechanism by which
this occurs can not be identified at this time.
This is in contrast with the results obtained in the fifth experiment, where
there was not a difference in cell number of the bovine embryos co-cultured in the
presence of cells expressing the HPRT gene and cells lacking HPRT activity. This
clearly brings into question the suitability of the use of mouse embryos as a model
for bovine embryo development.
The last experiment compared the sex ratio of bovine blastocysts cultured
with two HPRT inhibitors and an HPRT inducer. The embryos cultured with the
HPRT inducer (hypoxanthine) did not have altered sex ratios as was noted with the
control embryos and those cultured with the HPRT inhibitors. The fact that
hypoxanthine is nontoxic and did not hindered the embryo development, may lead
to its use in human IVF programs where it is desirable to culture embryos to the
blastocyst stage without altering the sex ratio.
Based on the findings presented herein with the mouse embryos and the
HPRT gene, the cell model is updated (Figure 29). This hypothesis states that
following the massive degradation of mRNA during genomic activation there is an
altered rate of development of the blastocoel between male and female embryos.
This results from the increased shunting of phosphoribosyl phyrophosphate into
GTP. This decreases the availability of ATP for use by the Na+/K+ ATPase to
develop the blastocoel in female embryos because of the action of two HPRT
genes. This is exacerbated in the presence of increased glucose levels in vitro due
to the positive feedback of hypoxanthine on glucose transport. This leads to
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Figure 29. Mouse embryo HPRT sexual dimorphism hypothesis. Adenine
phosphoribosyl transferase (APRT), hypoxanthine phosphoribosyl transferase
(HPRT), inosine monophosphate (IMP), guanine monophosphate (GMP) adenosine
diphosphate (ADP) and adenosine triphosphate (ATP).
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increase glucose metabolism to phosphoribosyl pyrophosphate via the pentose
phosphate shunt.
It is hoped that the results presented herein will spur further investigations
to confirm the validity of the hypothesis presented.
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